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Asthma is the most common chronic disease of  childhood, with an increasing preva-
lence worldwide over the last decades.1,2 The keystone of  current asthma management 
is the regular use of  inhaled corticosteroids (ICS), the effectiveness of  which has been 
shown by large trials, starting from the seventies of  the last century.3 Although these 
studies were widely confirmed, physicians and patients were slow to adopt the use of  
ICS, perhaps because their effects on the airways were delayed compared with those 
achieved with bronchodilators.3 However, over time, it became clear that ICS were 
effective in asthma treatment and safe relative to the use of  systemic corticosteroids. 
Therefore, all evidence-based asthma guidelines now recommend the prescription 
of  ICS to children with persistent asthma. Despite the effectiveness and widespread 
use of  ICS, many asthmatic children continue to suffer from uncontrolled asthma.4 
Because poor adherence to ICS is the rule rather than the exception (table 1),5,6 this is 
thought to be a major cause of  the limited effectiveness of  ICS in achieving asthma 
control in most children. 
Improving adherence to ICS in children with asthma probably is the most effective 
method through which health care providers can reduce the burden of  uncontrolled 
asthma. Knowledge of  the reasons for such poor adherence, however, is required to 
improve adherence. Therefore we designed a series of  studies on determinants of  
adherence to ICS in children with asthma. This thesis reports the results of  these 
studies. In this introduction, I will provide a broad overview of  the state of  research 
on adherence in paediatric chronic conditions, based on work summarized in several 
reviews on adherence.7-11 The introduction will be followed by a description of  the 
theoretical framework underlying this thesis. At the end of  this chapter, the scope of  
this research project is presented in more detail together with the further outline of  
this thesis.
ADHERENCE: A DEFINITION
Adherence to a medication regimen is generally defined as the extent to which the 
amount of  medication patients take corresponds with agreed recommendations from 
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a health care provider.5 Children with persistent asthma are recommended to use ICS 
daily throughout the year as a preventer medicine.12 When parents of  those children 
administer the medication once daily instead of  a recommended two doses per day, 
adherence is 50%. A child whose parents decide to administer the medication only in 
episodes with symptoms (instead of  the whole year), for example for 20 weeks annu-
ally, will have an adherence of  20/52*100% = 38%. These two different patterns of  
non-adherence behaviour illustrate the multi-faced character of  non-adherence (table 
2). The term adherence, therefore, does not hold any explanation of  the pattern and 
reasons of  medicine taking behaviour of  patients (and their parents), and is intended 
to be a non-judgmental statement of  fact rather than a declaration of  blame of  the 
patient or parent.9
Table 1. Overview of adherence studies in asthmatic children using electronically measure-















Bender23, 2000 27 7-12 6 Patient related factors Mean 50%
Berg24, 2007 48 8-12 0,5 Patient and Asthma related 
factors, Child’s perception of hope
Median 71%
Burgess25, 2008 51 2-17 1 Patient realated factors Median 71%
Celano26, 2010 143 6-11 0,5 Patient realated factors Mean 57%
Fiese27, 2005 72 5-18 12 Patient realated factors Not reported
Gibson28, 1995 29 1-5 2 Patient and Asthma related 
factors
Median 77%
Ho29, 2003 155 7-17 12 Patient and Asthma related 
factors
Mean 50%
Jentzsch30, 2012 102 5-14 3 Asthma related factors Median 44%
McNally31, 2009 63 5-17 12 Asthma related factors Mean 33%
McQuaid32, 2003 106 8-16 1 Child’s reasoning about asthma Median 48%
Modi33, 2006 36 6-13 3 Patient and Asthma related 
factors
Not reported





90 1-11 3 Patient related factors and 
medication beliefs
Mean 49%
*Correlates and predictors of adherence divided into:
1. Patient related factors such as socio-economic status, ethnicity, family routines or know-
ledge about asthma.
2. Asthma related factors such as asthma control and health utilisation.
3. Parental views or child’s perspectives about asthma or treatment in italics in the table
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Table 2. Different patterns of non-adherence (adapted from21)
erroneous non-adherence Caused by poor instructions by health care providers or insuffi-
cient understanding of the treatment rationale on the part of the 
patient.
unplanned non-adherence Related to barriers to adherence such as child-raising issues, limi-
ted family (medicine taking) routines and lack of motivation.
intentional non-adherence Refers to patients who deliberately choose not to follow the 
doctor’s recommendations.
ADHERENCE: THE PROBLEM
Low adherence with prescribed treatments is very common, in particular with long-
term therapies. Typical adherence rates for prescribed medications are about 50%, and 
rates of  adherence among patients with asthma range from 30% to 70% (table 1).5 
Poor adherence to long-term therapies severely compromises the effectiveness of  
treatment and accounts for substantial worsening of  disease, death, and increased 
health care costs.8 It is clear that the full benefit of  the many effective medications 
that are available (e.g. ICS in children with asthma) will be achieved only if  patients 
follow prescribed treatment regimens reasonably closely. There is growing evidence to 
suggest that because of  the alarmingly low rates of  adherence, increasing the effecti-
veness of  adherence interventions may have a far greater impact on the health of  the 
population than any improvement in specific medical treatment.5 Without a system 
that addresses the determinants of  adherence, advances in biomedical technology will 
fail to realize their potential to reduce the burden of  chronic illness.5
IMPROVING ADHERENCE: THE EVIDENCE
Studies on interventions to improve adherence to long-term therapies have shown 
only small, if  any, improvement in adherence, with only a minority of  interventi-
ons leading to improvement in at least one treatment outcome.9 Almost all effective 
interventions improving adherence to long-term therapies were complex and, there-
fore, costly.8,10 In asthma, educational interventions alone are insufficient to promote 
adherence in children and adolescents.10 Incorporating a behavioural component (e.g. 
monitoring and goal setting, reinforcing medication taking with rewards, problem 
solving and linking medication taking with established routines) to adherence inter-
ventions is needed to increase potential efficacy.10 The disappointing effects of  many 
adherence interventions, combined with the slow progress adherence research has 
made over thirty years, has motivated researchers to delve further into the reasons why 
some adherence interventions are effective and others are not, the underlying theoreti-
cal frameworks which might help to explain these differences in efficacy, and what re-
search and development is needed to develop more effective interventions and health 
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care practices to optimize adherence.7 In a comprehensive review of  reviews on adhe-
rence, van Dulmen and coworkers noted that only two reviews included studies with 
a follow-up of  at least 6 months. This limited the authors’ ability to draw meaningful 
conclusions on interventions capable of  fostering long-term improvements in adhe-
rence. Together with the complexity of  many adherence interventions and the lack of  
studies explicitly comparing components of  adherence interventions, effective com-
ponents within promising theories could not be identified.7 This may also be related to 
the multi-faceted character of  non-adherence which is not taken into account in most 
adherence studies (table 2).13 Because of  the different forms of  non-adherence, pro-
bably no single theoretical framework can explain the non-adherence phenomenon.13 
Therefore, experts encouraged a more fundamental shift in focus, moving away from 
conceptualizing non-adherence as a fault of  the patient. Future adherence studies 
should focus on patients’ perspectives and the support needed by patients to find their 
way in self-management: ‘patients should be supported, not blamed’.5,13 This concept 
of  patients self-managing their illness is discussed in the next section, together with a 
theoretical framework that takes the role of  patients’ perspectives into account. 
ADHERENCE, A PERSPECTIVE OF SELF-MANAGEMENT AND 
SELF-REGULATION
Self-management is the key to successful management of  chronic illness. It can be 
estimated that an ‘average’ patient will have direct face-to-face contact with a health 
professional in the health care system about one hour per year, which means that 
during the other 8759 hours of  the year the patient has to manage his or her illness 
without health care providers.14 Barlow and colleagues have defined self-manage-
ment as follows:
“… the individual’s ability to manage the symptoms, treatment, physical and psychosocial conse-
quences and life style changes inherent in living with a chronic condition. Efficacious self-manage-
ment encompasses ability to monitor one’s condition and to effect the cognitive, behavioural and 
emotional responses necessary to maintain a satisfactory quality of  life.”15 
Self-management skills are diverse and include behaviours such as gathering infor-
mation, managing medication (including adherence), symptoms and psychological 
consequences, adjusting lifestyle, mobilizing and drawing on social support, and 
communicating effectively.14 
Recent research on self-management and adherence in various chronic conditions 
lends support to a theoretical model which has become known as the ‘Common Sense 
Model’ (fig.1).14 In this model, the central tenet pertains to people making sense of  
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physical sensations, and the steps they take as a result of  this process of  sense ma-
king.11 A patient with asthma who perceives the asthma to have an episodic nature 
will not perceive the necessity to take preventive medication. This ‘no symptoms, no 
asthma’ behaviour will lead to inadequate control of  asthma.16,17 On the other hand, 
a patient who perceives the asthma to be a chronic condition that necessitates main-
tenance medication will adhere to medication use, therefore, and will have a higher 
chance of  controlling her asthma. Patients create their own personal cognitive repre-
sentation of  their illness which include beliefs about what may have caused the illness, 
the consequences the illness will have on their lives, how long the illness will last, and 
whether or not it is controllable or curable. In parallel, they also develop emotional 
responses to the threat. The cognitive and emotional representations of  symptoms 
and illnesses are called illness perceptions.11 “Illness perceptions are shaped by early 
experiences with illness-related episodes (e.g. flu, fall), in which children learn how 
to respond to pain and discomfort from their parents, and by imitating siblings and 
other children, for example, stay home or continue daily activities as much as possible. 
In addition, public images of  how to respond to various complaints and illnesses are 
learned by watching television, surfing the Internet, lay press publications, and by lis-
tening to stories of  parents, teachers and physicians. Illness perceptions, therefore, are 
strongly influenced by cultural, social and psychological factors, and are hardly, if  at 
all, determined by the ‘objective’ medical severity of  the symptoms or by age, gender, 
intellectual capacity or socio-economic class of  the patients.”14 Such illness percepti-
ons have been found to determine self-management behaviour and outcomes (fig. 1).14
Figure 1. The Common Sense Model, (adapted by Orbell & Hagger)15
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An extended self-regulatory theory that includes treatment beliefs as well as illness 
perceptions has been put forward in particular by Horne et al., whose research showed 
strong correlations between treatment beliefs and adherence (fig 2).18 In adult patients 
with asthma, self-reported non-adherence was associated with doubts about the neces-
sity for preventer medication to maintain health and with concerns about the potential 
adverse effects of  this medication.19 Necessity beliefs and concerns appeared to be 
separate constructs and not opposite poles of  a more general attitude towards prescri-
bed medication.19 Horne et al.’s observation that treatment beliefs were substantially 
and independently related to adherence is consistent with findings in a range of  chro-
nic illness samples.18 In agreement with these findings, a number of  qualitative studies 
suggested that parental perceptions about illness and medication are major determi-
nants of  the use of  controller medicines in their children.20,21 An overview of  (most 
very recent) quantitative studies supporting this, is provided in the general discussion 
of  this thesis together with the results of  the present project. Before discussing the 
scope and outline of  this thesis, first an overview of  limitations in present studies on 
adherence in children with asthma is provided.
Figure 2. A theoretical model of the relationship of illness perceptions, medication beliefs and 
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Limitations in studies on adherence in children with asthma. 
• Most studies on adherence in children with asthma have focused on the role of  
disease severity, asthma knowledge, and socio-economic factors in explaining 
adherence (table 1). There is a paucity of  studies conceptualizing adherence 
from a self-regulation perspective, with illness perceptions and treatment beliefs 
as key predictors of  adherence. 
• Many studies on determinants of  adherence in childhood asthma were of  rela-
tively short duration, while long-term adherence is the focus of  interest. 
• Most studies rely on subjective measures of  adherence such as self-report by 
parents or children or on estimation of  adherence by physicians. Research has 
consistently shown such subjective measures to be highly unreliable, overes-
timating the rate of  adherent patients which interferes which study results.36 
Canister weight and electronic monitoring are the most accurate measurements 
of  adherence.37 Of  the studies relying on such objectively measured adherence, 
only a few conceptualized adherence from a self-regulation perspective (table 1).
• Adherence studies in preschool children with asthma are very rare. 
There appears to be an urgent need, therefore, to improve the knowledge on long-
term adherence to maintenance treatment, and its determinants, in children with 
asthma. In particular, the importance of  illness beliefs and treatment beliefs in 
determining adherence should be explored in more detail. Such studies should rely 
on objectively measured adherence. Developing this research further will be helpful 
in constructing applicable interventions to optimize adherence, and thus improve 
asthma control.
AIMS AND METHODS OF THIS STUDY
This study was designed to examine determinants of  long-term adherence to daily 
maintenance treatment, measured objectively and reliably, in children with chro-
nic persistent asthma. The primary objective was to test the hypothesis that illness 
perceptions and treatment beliefs are more important in determining adherence than 
demographic and socio-economic factors, or the severity of  the disease. The project 
was primarily set in a secondary care asthma clinic, because adherence to therapy was 
assumed to be more important in patients with more severe disease, as compared to 
children with mild intermittent disease being treated and monitored in primary care. 
The results of  the initial focus group study of  this research-project, in which parents 
whose children were being followed up in primary and in secondary care, respectively, 
reported striking differences in the organization of  health care and in illness per-
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ceptions and treatment beliefs between primary care and secondary care, suggested 
that the organization of  health care was a significant determinant of  adherence. This 
prompted us to extend this study to primary care practices in the catchment area of  
the hospital-based asthma clinic.
The project consists of  three complementary studies. In study 1, illness perceptions 
and medication beliefs of  parents of  asthmatic children were explored in semi-struc-
tured focus group interviews. In study 2, adherence to daily inhaled corticosteroid use 
was examined over a 12-months period with electronic adherence logging device, in 
a large sample of  children, 2-12 years of  age, with chronic persistent asthma, both in 
primary and in secondary care. Patients and their parents were characterized exten-
sively to identify factors associated with both poor and good adherence. The illness 
perceptions and treatment beliefs of  parents were assessed with validated and stan-
dardized questionnaires.  We also studied the importance of  adherence in determining 
long-term asthma control. Asthma control was assessed by parents and physicians, 
in chart review and by measuring lung function, as proposed by international asthma 
guidelines.
Study 3 was a qualitative study designed to explore additional reasons for non-adhe-
rence. Parents who consented to de-blinding of  study results after completing study 2 
were interviewed about their medicine-taking behaviour.
OUTLINE OF THIS THESIS
In chapter two, the results of  the focus group interviews (study 1) are presented. The 
results of  study 2 are presented in four different chapters. First, preliminary results of  
3-months adherence in children 2-6 years are presented in chapter 3. The inclusion of  
children with persistent asthma in primary care was hampered by liberal prescription 
of  ICS by general practitioners to children with nonspecific respiratory symptoms, as 
described in chapter 4. The main analysis of  determinants of  long-term adherence 
in primary care and secondary care is reported in chapter 5. The role of  long-term 
adherence in acquiring and maintaining well-controlled asthma in children is described 
in chapter 6. Results of  the interviews with parents who completed the 1-yr follow-up 
on their reasons and motives to adhere or not to adhere to daily maintenance medica-
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Asthma treatment according to guidelines fails frequently, 
through patients’ non-adherence to doctors’ advice. This study 
aimed to explore how differences in asthma care influence 
parents’ perceptions to inhaled corticosteroids (ICS). 
Methods
We conducted six semi-structured focus groups, including 44 
parents of  asthmatic children (2–12 years of  age, treated in 
primary or specialist care). Verbatim transcripts were analysed 
with standard qualitative research methods. 
Results 
Parents decided deliberately whether ongoing ICS use was 
useful for their child. This decision was based on their percep-
tions about illness and medication. In primary care, this issue 
was hardly ever discussed with the health care provider because 
regular scheduled follow-up was unusual. In specialist care, 
regular scheduled follow-up was usual, and parental perceptions 
about illness and medication were discussed and modified when 
needed. Parent-reported adherence was lower in primary care 
than in specialist care.
Conclusion
This focus group study illustrates how strongly parental 
perceptions of  illness and medication influence adherence to 
health care providers’ advice and that such perceptions can be 





Low adherence to inhaled corticosteroid (ICS) treatment in children with asthma is 
one of  the main reasons why asthma is still associated with significant morbidity, and 
goals set in the GINA guidelines are frequently not met.1-3 Reasons for poor adheren-
ce to ICS are not fully understood, but patients’ perceptions about illness and medi-
cation appear to be at least as important as external, non-modifiable factors such as 
socio-economic status and race.4-8 Because most health care providers do not discuss 
patients’ perceptions of  their illness and its medical management during the consulta-
tion, they are frequently unaware of  differences between the parents’ perception and 
the professional model of  the disease.9 This makes it impossible to focus on such dif-
ferences. Building a partnership with patients (and their parents), as suggested by the 
most recent revision of  the guidelines, may improve awareness of  different perspecti-
ves between patients and physicians.10 However, the way such partnership is reached is 
different between primary care and specialist care caused by differences in organizati-
on. Most asthma care takes place in primary care, where patients and physicians tend 
to have a long-standing relationship. Most primary care physicians provide asthma care 
without specific support from specialized asthma nurses, and planned follow-up visits 
are uncommon – the decision to visit the doctor is primarily made by the parents.11 
According to their guidelines, primary care physicians refer patients to specialist care 
when asthma control is not achieved by low-dose ICS maintenance treatment. In our 
paediatric specialist clinic, asthma care is delivered by paediatric chest physicians to-
gether with asthma nurses, and all newly referred patients receive comprehensive and 
tailored asthma education.12 We schedule frequent follow-up visits until guideline goals 
for treatment are met. This study aimed to explore how these differences in asthma 
care influence parents’ perceptions about asthma, its treatment and how they qualify 
the relationship with their health care providers. A qualitative approach was chosen 
because this allows a rich interpretation of  patients’ perspectives, experiences and ro-
les.13 By organising focus groups, we aimed to reach dynamic conversations where the 




We performed a focus group study according to published guidelines.14 Six focus 
groups of  parents of  children with asthma were convened: three from the paedia-
tric asthma clinic at our hospital and three from five primary care practices in the 
catchment area of  our hospital. These practices represented city and rural area, and 
small and large practices. The family physicians involved had contributed to previ-
ous research of  our paediatric asthma clinic; they had expressed an interest in child-
hood asthma care and were supportive of  regional guidelines for the management 
of  asthma. Parents of  children aged 2–12 years with a doctor’s diagnosis of  mild to 
moderate persistent asthma who had received at least one prescription for ICS in the 
last year were eligible for inclusion in the study. From an alphabetic list, consecutive 
parents were approached, and after giving informed consent, they were included until 
groups were full (eight parents). No pre-set characteristics of  parents or children were 
used for inclusion, because characteristics that determine parental perceptions are 
unknown. 
Each focus group interview, which lasted approximately 2 h, followed a semi-structu-
red interview guide of  10 open-ended questions, asking parents about their percepti-
ons of  asthma and its treatment, and on the organization of  care. The interviews were 
led by a professional journalist without specific medical knowledge, who encouraged 
parents to express their views freely and who clarified views and expressions where 
needed. One of  the authors (TK) attended the sessions, took field notes and debriefed 
the moderator after each interview to record her impressions of  emerging themes. 
This information was used to structure the subsequent focus group interviews. After 
reviewing the transcripts of  six focus groups, it was concluded that saturation had 
been reached.14 Each focus group was audio-taped and transcribed verbatim prior to 
data analysis. 
Before conducting the focus groups, a codebook was put together, including items 
from the beliefs about Medicines Questionnaire.15 New codes were added for emer-
ging themes from field notes, debriefing and during the coding process itself, to allow 
capturing all relevant data. The transcript of  the first focus group interview was coded 
independently by two researchers (TK, HR). Cohen’s Kappa was 0.78 (where 0 = no 
agreement and 1 = perfect agreement), indicating good agreement for classificati-
on by code. Subsequent transcripts were coded by one of  the researchers (HR) and 
cross-checked by another (TK). Differences in coding were resolved by consensus. 
Codes were grouped into three themes: parental perceptions about illness and medica-
tion, self-management including self-reported adherence and issues relating to asthma 
care and health care providers. A provisional theoretical model explaining the results 




The Medical Ethics Review Board of  our hospital judged that this study, because it in-
volved only adult volunteers, did not require formal ethical approval under Dutch law.
RESULTS
From the primary care practices, parents of  38 children were invited to participate. 
Parents of  20 children consented, and 24 parents, representing 18 children, attended. 
From the paediatric asthma clinic, parents of  42 children were invited to participate, 
parents of  17 children accepted and 20 parents representing 16 children participated. 
All parents had full health insurance (which is mandatory in the Netherlands), most 
were Caucasian (which comprises >90% of  patients in the catchment area of  our 
hospital) and most were from (upper) middle class backgrounds. The mean age of  the 
children of  the parents in the focus groups was 5.7 years, ranging from 2 to 12 years. 
Fourteen children were under the age of  five and had primarily viral-induced wheeze 
exacerbations. Most preschool viral-induced wheeze patients from secondary care 
were hospitalized for an exacerbation, whilst none of  the patients from primary care 
had ever been referred or admitted to hospital. All children 5 years of  age or older 
had mild to moderate persistent asthma; the large majority were atopic. The principal 
findings of  the focus group interviews are presented separately for primary care and 
specialist care. These findings are illustrated by quotes about common perceptions of  
illness and medication and about health care providers (Table 1).
Primary care
Parents reported that after the initial visits to the health care provider, during which a 
diagnosis was made and maintenance medication was prescribed, they did not receive 
regular follow-up appointments. Parents would receive repeated inhaled corticosteroid 
prescriptions for their child without seeing a health care provider for up to three years, 
with parents managing their child’s asthma on their own. Parents would only visit the 
health care provider when they could not manage their child’s asthma problems by 
themselves anymore. Parents considered this method of  self-management without 
consulting a health care provider as entirely logical. They were comfortable with it, be-
cause they viewed themselves as being responsible for making decisions on issues such 
as medication use. These decisions were based on their perceptions about illness and 
medication (Table 1). Consequently, they used the prescribed medication depending 
on how they valued their child’s need for medication and on their concerns regarding 
medication use. If  parents were convinced of  the necessity of  using ICS, this was 
mostly because they had observed an improvement of  their child’s symptoms after 
starting ICS, or it was based on an experience in the family that patients with asthma 
benefit from ICS. Although some of  these parents would give ICS on a daily basis to 
26
Chapter 2
Similarities in primary care group and secondary care group
Views on the partnership with the health care provider for taking decisions on treatment
‘The paediatrician suggested to lower the dose, but I said; he is now doing well, let’s keep the 
dosage at two times a day’.
‘When my son has an asthma attack, I know he will receive oral prednisone when we visit the 
doctor. But I prefer he recovers without. Therefore, together with my husband we decide 
when the problems with breathing are severe enough to visit the doctor for receiving a pres-
cription for oral prednisone’.
‘I think the time changed that doctors are the ‘all-knowing’. Therefore, nowadays it is more a 
two-way conversation. Again, it is your child, you know the best if he is ill’.
‘In general, we don’t have to debate very much, the doctor takes usual the decision we had in 
thought’.
‘When I say I want to stop de medicines, the asthma nurse does not automatically reject my 
idea. Her reaction is that the complaints of my child can return in a very severe way, so she 
keeps mentioning the importance of the medicines. But she does not say I can’t do that. This 
in contrary with the general practitioner’.
Perceptions about resistance to medicines in general
‘It is poison’ ⁄ ‘It is trash’⁄ ‘Medicines are bad’.
‘I don’t like medicines altogether’.
‘That doctor said that there are no side effects when using this medicine for a long period of 
time, but in the past they were saying that about a lot of medicines, and
they turned out to be wrong’.
Differences between primary care group and secondary care group
Perceptions about asthma and the treatment 
with ICS in the primary care group
Perceptions about asthma and the treat-
ment in the secondary care group
‘Most illnesses in children disappear by them-
selves’
‘If you continue preventive medicine you 
can never find out whether the child can do 
without’
‘I compare it with a sprained ankle: maybe you 
need crutches first, but for full recovery you 
have to walk without them’
‘We wanted to find out how he would do 
without his medicine. Well, he was fine. So now 
we only give the medicine when he needs it’
‘I don’t want to burden my child with medicine 
of which I am not sure it will help. With salbu-
tamol, it is clear, but with fluticasone, you just 
have to assume that it works. And that is really 
difficult’ ‘It doesn’t work as well when you use 
it on a daily basis’
‘Her asthma may not disappear, but with 
the medicines you can suppress it’
‘The well-being of my daughter depends on 
the use of the medication’
‘First I thought that periods with no 
symptoms means she had control over the 
asthma by herself and medicines were no 
longer needed. Now I have learned this is 
the wrong assumption’
 ‘The fluticasone is a preventive medicine, 
I try to say, just take your meds, you can 
reach the age of one hundred years using 
them’
 ‘If you are thinking about the kind of me-
dicines you put into your child, sometimes 
it upsets you, but asthma upsets you more. 
So, you have to give the medicines’
 ‘He uses it on a daily basis, it prevents 
complaints’
Table 1. Parental quotes from the interviews illustrating the key findings
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their child, most would use ICS only intermittently or stop it altogether, arguing that 
their child’s asthma was not severe enough to justify daily use of  medication. Most 
of  these parents expressed resistance against medicines in general; the feeling that 
children should use as few medications as possible was common. Persistent asthma 
symptoms in the children were described frequently. Parents regarded these symptoms 
as belonging to having asthma and not as a reason to visit the health care provider 
or to step up medical treatment. Parents described the asthma care and the amount 
of  information received as minimal, but adequate, and they were satisfied with their 
primary care practitioner. 
Specialist care 
Parents reported that in specialist care, all children received regular follow-up by the 
paediatric chest physician and by the asthma nurse, with a frequency of  at least two 
visits a year. All parents were convinced of  the necessity of  ICS, preventing their 
children from having symptoms. This belief  was consistent between parents, although 
concerns about the use of  medication in general were common. These parents ex-
pressed the opinion that their child’s need of  being treated with ICS outweighed their 
concerns regarding the risks of  daily use of  ICS. Although all parents reported to be 
adherent to the advice of  daily use of  ICS, those with strong concerns about medicati-
on were eager to diminish the dose. As follow-up was regular, they felt free to discuss 
this topic with the health care provider, and in their opinion changing the medication 
dosage was a shared decision between parents and the medical team. Parents were 
very satisfied with the asthma care. They particularly valued the fact that they were 
taken seriously and that they were acknowledged as the people knowing their child 
best. The asthma nurses were highly valued as being easily approachable, well-trained 
and because they provided lots of  practical advice. Parents felt free to discuss issues 
such as their concerns about medicines or the use of  alternative and complementary 
treatment with these nurses. Many parents expressed strong criticism about the health 
care providers in primary care. They did not feel having been taken seriously by these 
health care providers in their concerns about their children. Consequently, their view 
on their child’s symptoms and treatment differed from that of  the health care provi-
ders, and this prompted parents to ask for referral to specialist care. Parents emphasi-
zed that they had to be very assertive to receive the treatment that they felt their child 
needed. Another complaint about primary care was the limited amount of  informati-
on patients received, making it difficult to self-manage their child’s asthma.
28
Chapter 2
Feedback of  study findings to participating physicians 
The results of  our focus group studies were discussed with the family physicians and 
paediatric chest physicians in a group meeting. All participating physicians confirmed 
that the parents’ reports of  asthma care were a representative description of  current 
asthma care in their practices.
DISCUSSION
This focus group study with parents of  children with asthma provides important clues 
to understanding how differences in asthma care facilitate or hamper adherence to 
ICS treatment in children with asthma. Two main results emerged from the inductive 
analysis of  the focus group interviews. 
First, parents play a pivotal role in the management of  their child’s asthma. Health 
care providers can not force asthma treatment upon these children; parents decide 
whether they will follow medical advice for their child’s condition. This parental deci-
sion is based on their own perceptions about illness and medication. Even a satisfying 
long-term relationship with the primary care physician does not prevent parents from 
critically approaching prescriptions for maintenance medication for their child. This is 
in accordance with previous qualitative studies’ findings showing how parents take the 
medical care of  their child’s asthma into their own hands by balancing the perceived 
need for ICS against their concerns about (side effects of) medication.4,16-18 This fin-
ding emphasizes the importance of  parental perceptions about illness and medication 
and illustrates how strongly such perceptions influence parental behaviour regarding 
health care providers’ advice.4-6,8 
Second, the results of  this study strongly suggest that these powerful parental percep-
tions about illness and medication can be modified by health care providers during 
close and intensive follow-up. In contrast to parents in primary care, most parents 
in specialist care adopted the professional model of  asthma (Table 1). The regularly 
scheduled follow-up in specialist care and the involvement of  asthma nurses offer the 
opportunity to listen carefully to parents, to explore and understand their views on ill-
ness and their attitudes towards asthma medication, which is needed to develop a true 
patient ⁄ parent–doctor partnership. Being aware of  the family’s needs and percepti-
ons, tailored information can be given.19 Our results support the hypothesis that such 
close follow-up allows modification of  these parental perceptions about illness and 
medication.20 This underscores the importance of  building a partnership with parents, 
characterized by listening to their views and perspectives on illness and medication 
and by shared decision making. Modifying parental illness and medication perceptions 
during long-term close follow-up allows better self-management and improved adhe-
rence to health care providers’ advice. This helps to understand how quality impro-
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vement strategies for childhood asthma care, including communication education of  
physicians or group discussions with parents based on the concept of  concordance, 
improve asthma outcome.21,22 
Although our findings strongly suggest that the observed differences in parental 
perceptions about illness and medication between primary care and specialist care 
were caused by the different organization of  care, other explanations must be con-
sidered. It could be argued that a higher degree of  asthma severity or poorer asthma 
control in patients from specialist care increased the parental sense of  usefulness of  
maintenance medication for their child. Although we did not formally assess asthma 
severity and control level in the children with asthma whose parents we interviewed, 
the overall impression from the focus groups was that the degree of  asthma severity  
as similar between children from primary and specialist care, the only difference being 
a larger history of  hospitalizations in the secondary care group children. Although this 
may have affected parental perceptions on usefulness of  medication in the preschool 
children concerned, it can not explain the large differences in parental perceptions 
between the whole secondary care group when compared to the primary care group. 
Furthermore, children in primary care appeared to have poorer asthma control with 
frequent asthma symptoms, and this did not affect the parents’ view on the usefulness 
of  maintenance medication. Previous studies from the USA and from the Netherlands 
have also shown little difference in childhood asthma severity between primary and 
specialist care.11,23 
Focus group methodology was chosen because this is superior to quantitative sur-
veys in exploring parents’ perspectives and beliefs on the management of  asthma.13 
However, the time- and labour-intensive nature of  qualitative research imposes the 
limitation that it can only be conducted with small samples. As a result, findings are 
not immediately generalizable to the larger population, in particular because most 
parents were Caucasian middle class with good access to health care and full health 
insurance. However, in a study among low-income urban families, caregiver and child 
perceptions about illness and medication were also found to be a major barrier to 
asthma care.8 Other studies showed that such perceptions hamper adherence more in 
low-income, minority populations.4,7 Although it might be tempting to think that such 
misperceptions about illness and medication are the result of  ignorance and would be 
more common in lower socioeconomic strata, our results, remarkably, show that such 
counterproductive parental perceptions about illness and medication are an impor-
tant barrier to adherence to maintenance treatment, even in a group of  affluent and 
well-educated parents. This stresses the importance of  a strong doctor–parent part-
nership where such perceptions can be discussed and modified. 
A final limitation is that we had no objective data on adherence in our study group, 
which could corroborate the parental reports of  adherence. Given the cross-sectional 
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nature of  our study, monitoring adherence with electronic logging devices or by weig-
hing canisters was not possible. It has been shown that checking pharmacy dispensing 
data on inhaled corticosteroids in children is as unreliable as parental reporting of  
adherence.24 Therefore, it is unlikely that we could have improved the accuracy of  our 
assessment of  adherence in the context of  this study. Although it is likely that parental 
reporting of  adherence is an overestimate of  true adherence, it is unlikely that this 
overestimation differed between the groups of  parents that we studied. 
In summary, this study shows the pivotal role parents have in the management of  
childhood asthma. Parental decisions about the treatment of  their children are highly 
influenced by their perceptions about illness and medication. This study suggests that 
health care providers can modify such perceptions by offering regular follow-up in 
which consultations are characterized by collaboration between health care providers 




1. van Dellen QM, Stronks K, Bindels PJ, Ory 
FG, van Aalderen WM. Adherence to inhaled 
corticosteroids in children with asthma and 
their parents. Respir Med 2008;102:755-63.
2. Rabe KF, Adachi M, Lai CK, Soriano JB, Ver-
meire PA, Weiss KB, et al. Worldwide severity 
and control of  asthma in children and adults: 
the global asthma insights and reality surveys. 
J Allergy Clin Immunol 2004;114:40-7.
3. Lasmar L, Camargos P, Champs NS, Fonseca 
MT, Fontes MJ, Ibiapina C, et al. Adherence 
rate to inhaled corticosteroids and their im-
pact on asthma control. Allergy 2009;64:784-9.
4. Conn KM, Halterman JS, Lynch K, Cabana 
MD. The impact of  parents’ medication 
beliefs on asthma management. Paediatrics 
2007;120:e521-6.
5. Smith LA, Bokhour B, Hohman KH, Mirosh-
nik I, Kleinman KP, Cohn E, et al. Modifiable 
risk factors for suboptimal control and con-
troller medication underuse among children 
with asthma. Paediatrics 2008;122:760-9.
6. Bender BG, Bender SE. Patient-identified 
barriers to asthma treatment adherence: 
responses to interviews, focus groups, and 
questionnaires. Immunol Allergy Clin North 
Am 2005;25:107-30.
7. Wells K, Pladevall M, Peterson EL, Campbell 
J, Wang M, Lanfear DE, et al. Race-ethnic 
differences in factors associated with inhaled 
steroid adherence among adults with asthma. 
Am J Respir Crit Care Med 2008;178:1194-201.
8. Laster N, Hlsey CN, Shendell DG, Mccarty 
FA, Celano M. Barriers to asthma manage-
ment among urban families: caregiver and 
child perspectives. J Asthma 2009;46:731-9.
9. Makoul G, Arntson P, Schofield T. Health 
promotion in primary care: physician-pa-
tient communication and decision making 
about prescription medications. Soc Sci Med 
1995;41:1241-54.
10. Global Initiative for Asthma. Global Strategy 
for asthma management and prevention. 2009 
update. Downloaded from http://www.ginast-
hma.org (date last accessed 23 August 2010)
11. Kuethe MC, Vaessen-Verberne AA, Bindels 
PJ, van Aalderen WM. Children with asthma 
on inhaled corticosteroids managed in general 
practice or by hospital paediatricians: is there 
a difference? Prim Care Respir J 2010;19:62-7.
12. Kamps AW, Brand PL, Kimpen JL, Maille´ 
AR, Overgoor-van de Groes AW, van Helsdin-
gen-Peek LC, et al. Outpatient management of  
childhood asthma by paediatrician or asthma 
nurse: randomised controlled study with one 
year follow up. Thorax 2003;58:968-73.
13. George M, Apter AJ. Gaining insight into 
patients’ beliefs using qualitative research me-
thodologies. Curr Opin Allergy Clin Immunol 
2004;4:185-9.
14. Krueger RA, Casey MA. Focus groups, a 
practical guide for applied research, 3rd edn. 
California: Sage publications, 2000.
15. Horne R, Weinman J, HankinsM. The Beliefs 
about Medicines Questionnaire: the deve-
lopment and evaluation of  a new method 
for assessing the cognitive representation of  
medication. Psychol Health 1999;14:1-24.
16. Dickinson AR, Dignam D. Managing it: a mo-
ther’s perspective of  managing a pre-school 
child’s acute asthma episode. J Child Health 
Care 2002;6:7-18.
17. Peterson-Sweeney K, McMullen A, Yoos HL, 
Kitzman H. Parental perceptions of  their 
child’s asthma: management and medication 
use. J Pediatr Health Care 2003;17:118-25.
18. Horne R, Weinman J. Self-regulation and 
self-management in asthma: exploring the 
role of  illness perceptions and treatment be-
liefs in explaining non-adherence to preventer 
medication. Psychol Health 2002;17:17-32.
19. Jokinen P. The family life-path theory: a tool 
for nurses working in partnership with fami-
lies. J Child Health Care 2004;8:124-33.
20. Kaptein AA, Hughes BM, ScharlooM, 
Fischer MJ, Snoei L, Weinman J, et al. Illness 
perceptions about asthma are determinants 
of  outcome. J Asthma 2008;45:459-64.
21. Cabana MD, Slish KK, Evans D, Mellins RB, 
Brown RW, Lin X, et al. Impact of  physician 
asthma care education on patient outcomes. 
Paediatrics 2006;117:2149-57.
22. Hederos CA, Janson S, Hedlin G. Six-year 




the management of  preschool children with 
asthma. Acta Paediatr 2009;98:1939-44.
23. Diette GB, Skinner EA, Nguyen TT, Markson 
L, Clark BD, Wu AW. Comparison of  quality 
of  care by specialist and generalist physicians 
as usual source of  asthma care for children. 
Paediatrics 2001;108:432-7.
24. Jentzsch NS, Camargos PA, Colosimo 
EA, Bousquet J. Monitoring adherence to 
beclomethasone in asthmatic children and 






adherence in childhood 











To study determinants of  adherence in young asthmatic child-
ren over a 3-month period, including the role of  parental illness 
and medication perceptions as determinants of  adherence.
Methods
Consecutive 2-6-yr-old children with asthma, using inhaled cor-
ticosteroids (ICS), followed-up at our paediatric asthma clinic 
(where patients are being extensively trained in self-manage-
ment, and are followed-up closely) were enrolled. Adherence 
was measured electronically using a Smartinhaler® and calcu-
lated as a percentage of  the prescribed dose. We examined the 
association of  adherence to a range of  putative determinants, 
including clinical characteristics and parental perceptions about 
illness and medication.    
Results
Median (interquartile range) adherence, measured over 3 
months in 93 children, was 92% (76-97%), and most children 
had well controlled asthma. 94% of  parents expressed the view 
that giving ICS to their child would protect him/her from be-
coming worse. Adherence was significantly associated with ast-
hma control and with parental perceptions about medication.  
Conclusion
The high adherence rate observed in our study was associated 
with parental perceptions about ICS need. The high perceived 
need of  ICS may probably be ascribed to the organisation of  





Adherence to maintenance therapy is of  key importance in determining the success of  
treatment of  chronic diseases, such as childhood asthma.1,2 Adherence to maintenance 
treatment, however, is poor, and this is a major cause of  uncontrolled asthma.1,3,4 Im-
proving adherence to inhaled corticosteroids (ICS) in children with asthma is probably 
the most effective method through which health care providers can reduce the burden 
of  uncontrolled asthma.1 In contrast with the common belief  among healthcare 
providers, parental asthma knowledge is hardly associated with adherence, and isolated 
educational efforts to improve asthma knowledge are ineffective in improving adhe-
rence.1,5 Socio-demographic factors and the severity of  asthma are also of  little impor-
tance in determining adherence to maintenance treatment in this disorder.1 Conversely, 
although adherence to ICS is notoriously poor among the urban-ethnic minority youth 
in the USA, with adherence rates between 37 and 50%, high adherence can be achie-
ved, even in such underprivileged populations, when patients are repeatedly educated 
about self-managing their chronic disorder and followed-up closely.6,7 This suggests 
that it is not the education per se, but rather the intensity, quality and frequency of  
education about self-management and follow-up that help to improve adherence. Stu-
dies aimed at interventions to improve physician-patient communication have shown 
better adherence and asthma control in children and adults with asthma.8,9
The association between such interventions and adherence maybe partially mediated 
by parental and patient’s illness and medication perceptions. Patients (and parents of  
paediatric patients) create their own personal cognitive representations of  their illness, 
including beliefs about what may have caused the illness, the consequences the illness 
will have on their lives, how long the illness will last and whether or not it is controlla-
ble or curable. The cognitive and emotional representations of  symptoms and illnesses 
are called illness perceptions.10 Similarly, medication perceptions comprise the patient’s 
(or parent’s) cognitive and emotional representations of  the medication prescribed; 
including method of  action, desired effects and side effects.11 Studies in adults have 
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shown that perceptions about illness and mediation are important drivers of  adheren-
ce. However, in childhood asthma care, the association between illness/medication 
perceptions and adherence has only been examined in qualitative or cross-sectional 
studies, and the importance of  such perceptions as determinants of  ICS adherence 
has not been studied in a quantitative fashion. Although asthma is very common in 
preschool children, only a few studies examined adherence to maintenance therapy 
and its determinants in this age group.1,11-15 Most of  these studies did not focus exclu-
sively on young children, only two used electronic adherence monitoring, and parental 
illness and medication perceptions received little attention. We designed this study to 
assess adherence, measured electronically, and its determinants, in children aged 2-6 
yrs with asthma during close follow-up in a paediatric asthma outpatient clinic. We 
hypothesized that adherence to ICS maintenance treatment in these patients would be 
associated with parental perceptions about illness and medication. 
METHODS 
For this study the parents of  all children aged 2-6 yrs with asthma, and currently 
treated with ICS, attending the Amalia Children’s clinic (Zwolle, the Netherlands) for 
regular follow-up, were asked to participate in the study. All children had a doctor’s 
diagnosis of  asthma based on more than three recurrent episodes of  wheezing and 
dyspnoea, and all were referred to our clinic by their general practitioner because of  
troublesome, severe, or frequent symptoms. In our clinic, we prescribe ICS to child-
ren with asthma as daily controller therapy, in accordance with the Dutch national 
guidelines on paediatric asthma, which are adapted from the Global Initiative for 
Asthma guidelines.2 Education and follow-up focuses on building and maintaining 
a strong partnership with patients and parents. We provide repeated tailored asthma 
self-management education, discuss parents’ perceptions about asthma and its treat-
ment, ensure concordance on treatment (goals) with parents, train correct inhalation 
technique and stress the importance of  adherence to daily ICS treatment.16 To achieve 
this, patients and their parents visit the clinic four to six times during their first year of  
follow-up, and two to four times per year afterwards. 
Exclusion criteria were limited knowledge of  the Dutch language and severe comor-
bidity. We collected clinical and demographic data by structured interview and chart 
review. Lung function was assessed before and after inhaling salbutamol 400 µg: 
flow-volume curves in children 5 yrs of  age and older, and resistance of  the respirato-
ry system measured by the interrupter technique was used for children < 5 yrs of  age 
(Microrint®), according to European Respiratory Society/ American Thoracic Society 
guidelines.17 Results were expressed as Z-scores. 
Upon entry into the study, a number of  validated questionnaires were applied; details 
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including references are presented in the online depository. Parental illness percepti-
ons were assessed by the Brief  Illness Perception Questionnaire (B-IPQ), and medi-
cation perceptions by the Beliefs about Medicines Questionnaire (BMQ), which also 
provides the balance between parent-perceived necessity and concerns about ICS, and 
the Treatment Satisfaction Questionnaire for Medication (TSQM).11,18,19 In addition, 
we applied the I Worry scale, which scored parental worries about their child having 
asthma and using daily ICS; the Medication Adherence Report Scale (MARS), which 
assessed self-reported adherence; the Satisfaction with Information about Medicines 
Scale (SIMS), the Paediatric Asthma Caregiver Quality Of  Life questionnaire (PAC-
QOL), and an asthma knowledge questionnaire.
Asthma control was assessed by a parent-completed Asthma Control Questionnai-
re (ACQ).20 The attending physician rated asthma control on a visual analogue scale 
ranging from 0 (worst asthma control possible) to 10 (complete asthma control) at a 3 
month follow-up visit. 
Patients used ICS by metered dose inhaler/ spacer combination during the 3-month 
follow-up period. Adherence was monitored by Smartinhaler®, a validated electronic 
device logging date and time of  each ICS actuation.21
Analysis
Adherence was calculated as the number of  Smartinhaler-recorded inhaled doses 
expressed as a percentage of  the number of  doses prescribed, and censored at 100% 
of  the prescribed dose. We assessed the association of  ICS adherence (both as a 
continuous variable and dichotomized as good (>80%) and poor (< 80%) adherence 
of  prescribed doses used) to all putative determinants (defined a priori with a focus on 
parental perceptions about illness and medication) in non-parametric univariate analy-
ses (because adherence had a highly skewed distribution).12 We chose to refrain from 
adjustments for multiple comparisons because of  the exploratory and observational 
nature of  our study.
Ethical considerations. 
This study was approved by the hospital ethics review board and all parents provided 




Out of  a total of  137 consecutive eligible patients, 103 children (75%) entered the 
study after informed consent was obtained, and 93 children (90% of  those enrolled) 
completed the 3 month follow-up (figure 1). Most parents who did not participate in 
or withdrew their child from the study did so because of  serious illness in a family 
member or other pressing circumstances. Clinical characteristics of  participating and 
non-participating children were comparable (table 1). Most participating children had 
well controlled asthma while on ICS maintenance therapy. Reliable and reproducible 
lung function results could be recorded in 66 (71%) children, and sensitisation to inha-
lant allergens was available for 86 children (table 1). 
Figure 1. Inclusion of patients
137 eligible patients (aged 
2-6 yrs, chronic persistent 
asthma, using inhaled corti-
costeroids)
13 children were not eligible: severe 
comorbidity (n=2), problems with 
understanding Dutch language (n=4), 
remission of asthma (n=3), using devi-
ces not compatible with the Smartin-
haler® (n=4)
124 children asked to 
participate
Parents of 21 children declined parti-
cipation; most common reason was 
being too busy
103 patients enrolled
10 children were lost to follow-up: 
physician stopped or prescribed other 
maintenance medication (n=5), moved 
to other area (n=2), withdrawn by 
parents (n=3)










Subjects n 93 44
Male 56 (61) 26 (60%) 0.90
Age (yrs) 4.5 (2.2 to 6.8) 4.6 (2.1 to 6.9) 0.67
Duration of outpatient clinic asthma care 
before study (months)
17 (8 to 27) 17 (9 to 28) 0.58
Maintenance medication:
• inhaled corticosteroids (ICS) 86 (92) 42 (95%) 0.51
• ICS and long-acting bronchodilators 7 (8) 2 (5%) 0.51
• ICS (fluticasone) dose (μg) 250 (125 to 500) 250 (125 to 500) 0.73
Scheduled visits to outpatient clinic in year 
before study
5 (4 to 6) 4 (2 to 5) 0.007
Hospitalisations in year before study 0 (0to 5) 0 (0 to 1) 0.007
ACQ baseline (<0.75 = well-controlled asth-
ma, >1.5 = not well-controlled asthma)
0.5 (0.2 to 1.3) NA NA
PACQoL baseline (score 1 to 7, with 1 is low 
and 7 is high quality of life)
6.2 (5.3 to 6.8) NA NA
Smoking parent(s) 28 (30%) NA NA
Educational level of mother (1 = low and 7 
= high)
5 (4 to 7) NA NA
Positive specific IgE to common inhalant 
allergens
43 (50) ¶ 24 (65) ǂ < 0.001
FEV1 baseline# 0.66 ± 1.1 NA NA
FVC baseline# 0.29 ± 1.3 NA NA
Rint baseline# 1.90 ± 2.8 NA NA
Data are presented as n (%), median (interquartile range) or mean ± SD, unless otherwise speci-
fied; ACQ: Asthma Control Questionnaire20; PACQOL: pediatric asthma caregiver quality of life 
questionnaire; Ig: immunoglobin; FEV1: forced expiratory volume in one second; FVC: forced 
vital capacity; Rint: respiratory resistance by the interrupter technique; NA: not available. #: 
z-score, n=33; ¶: n=86; ǂ: n=37.
The frequency distribution of  adherence to daily ICS is presented in figure 2. Median 
(interquartile range (IQR)) adherence was 92% (76% to 97%). Sixty-seven children 
(72%) had good adherence (>80% of  prescribed dosages); adherence rates below 60% 
were recorded in only eight (9%) children (figure 2). There was a small, non-significant 
decrease in adherence from the first to the third months of  follow-up (median (IQR) 
-1% (-8% to 1%); p=0.483). Adherence rates were comparable between children aged 
2-4 yrs (median 92%) and children aged 5-6 yrs (median 92%, p= 0.899). 
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The association of  adherence to the individual item responses on each questionnaire 
is presented in the online depository. Parental perceptions about illness were not asso-
ciated with adherence, but perceptions about medications were. Parents who believed 
that ICS maintenance treatment is needed for their child’s health, those who viewed 
ICS administration as convenient, and those who expected little harm of  medicines in 
general had higher adherence rates to ICS (table 2). The other putative determinants 
that showed significant (p<0.05) or near-significant (p<0.1) association to adherence 
are presented in table 3. Not unexpectedly, parental self-reported adherence (as asses-
sed by MARS) was strongly related to electronically measured adherence. In addition, 
good asthma control was positively related to adherence measured electronically. Pa-
rental characteristics such as educational level, asthma knowledge and smoking habits 
were not significantly associated with adherence.  
For 84 (93%) parents, BMQ scores indicated that the perceived necessity outweighed 
concerns about ICS (table 4). This was mainly due to the large majority of  parents 
expressing the view that giving ICS to their child would benefit his/her health, even 
when they had concerns about the use of  ICS. The results from other questionnaires 
were consistent with this finding (see online depository for details). For example, only 
three parents responded negatively to the TSQM question “Overall, how confident are 























































Figure 2. Adherence to ICS measured by electronic loggers
Chapter 3
41





ren with high (>80%) and 
low adherence (<80%) of 
prescribed dosages taken
ρ p-value p-value
Brief Illness Perception Questionnaire
consequences 0.00 0.969 0.870
timeline -0.09 0.425 0.289
personal control 0.11 0.319 0.760
treatment control 0.11 0.294 0.526
identity -0.05 0.663 0.598
concern 0.00 0.970 0.835
understanding -0.08 0.440 0.260
emotional response 0.13 0.203 0.961
Beliefs about Medicine Questionnaire
Specific part: perception of necessity 0.22 0.035* 0.299
Specific part: concerns -0.01 0.949 0.368
Need-concern ratio 0.09 0.414 0.394
General part: perceptions of overuse 0.18 0.082 0.418
General part: perceptions of harm 0.23 0.025* 0.253
Treatment Satisfaction Questionnaire for 
Medication
effectiveness of daily use of ICS -0.10 0.342 0.633
side effects of daily use of ICS -0.01 0.963 0.838
convenience of administrating ICS to child -0.25 0.020* 0.212




Table 3.  Other putative determinants which showed a (near) significant (p<0.1) association 




ren with high (>80%) and 
low adherence (<80%) of 
prescribed dosages taken
ρ ρ-value ρ-value
MARS 0.53 <0.001 0.001
VAS asthma control by physician 0.26 0.028 0.009
ACQ at 3 months -0.19 0.105 0.036
Rint baseline¶ -0.33 0.060 0.056
Rint % change after bronchodilator¶ 0.41 0.016 0.006
FEV1 change after bronchodilator¶ -0.33 0.069 0.085
MARS: Medication Adherence Report Scale; Rint: respiratory resistance by the interrupter 
technique; FEV1change: difference in forced expiratory volume in one second before and after 
salbutamol; VAS: visual analogue scale; ACQ: asthma control questionnaire; ¶:n=33
Table 4. Parental beliefs about medication measured by the Beliefs about Medicines 
Questionnaire11
Agree Neutral Disagree
5 questions about need
My child’s health, at present, depends on his/her medicines 8.33 7.8 8.9
My child’s life would be impossible without his/her medicines 26.7 35.6 37.8
Without his/her medicines my child would be very ill 51.1 23.3 25.6
My child’s health in the future will depend on his/her medicines 24.7 43.8 31.5
My child’s medicines protect him/her from becoming worse 94.4 4.4 1.1
5 questions about concern
My child having to take medicines worries me 39.3 6.7 53.9
I sometimes worry about long-term effects of my child’s 
medicines
44.4 17.8 36.7
My child’s medicines are a mystery to me 4.5 7.9 87.6
My child’s medicines disrupt his/her life 1.1 3.3 95.6
I sometimes worry about my child becoming too dependent on 
his/ her medicines
28.9 10.0 61.1
Balance between need and concern
necessity beliefs higher than concerns 93.4 2.2 4.4




This study shows that high adherence to daily maintenance treatment with ICS along 
with good asthma control can be achieved in preschool children with asthma and that 
high adherence is associated with parental beliefs about the necessity of  ICS therapy. 
The median adherence rate in our study remained stable over 3 months of  follow-up 
at 92%, which is considerably higher than in earlier studies (adherence ranging from 
44% to 72%, decreasing strongly over time). For example, a recent study showed that 
adherence to an ICS prescribed after an emergency visit for acute asthma deteriora-
ted from 90% to 50% during the first two weeks after the acute asthma attack.22 This 
confirmed earlier population-based observations that most patients with asthma fail 
to continue ICS use after an initial prescription.23 Although some large studies showed 
lower adherence rates for adolescents than for school- and preschool-aged children, 
age is not consistently related to treatment adherence.1 Even in pre-adolescent child-
ren, adherence to ICS of  >75% of  prescribed dosages has rarely been described, 
neither in observational, nor in intervention studies.14 We emphasize that the very 
high adherence we observed was not the result of  an intervention aimed at improving 
adherence, but was obtained during routine care in our paediatric asthma outpatient 
clinic. 
The large majority of  parents of  the preschool children with asthma in our study 
expressed the belief  that ICS therapy for their child’s asthma was both useful and 
necessary (table 4). This is in contrast with previous studies examining medication 
beliefs in asthma. Studies in adults with asthma have shown lower BMQ “need” scores 
and higher “concern” scores.11,24 In a study of  622 parents of  children with asthma in 
the USA, concern scores exceeded need scores in 17% of  parents, compared to only 
4% in our study.15 Such concerns about the daily use and safety of  ICS in children are 
a major reason for parents to withdraw this medication in their children.25 Because the 
distributions of  ICS adherence (figure 2) and parental medication perceptions (table 
4) were strongly skewed towards high adherence and ICS necessity, with relatively little 
variance, the power of  our study to identify determinants for adherence was lower 
than expected. This may help to explain why we only identified a few parental percep-
tions significantly associated with adherence rates, and why these associations were 
relatively weak (tables 2 and 3).
We found a significant association between ICS adherence and asthma control, with 
poorer asthma control in patients with lower adherence, suggesting that this associ-
ation does not only play a role at the severe end of  the asthma spectrum, but also in 
patients with relatively well controlled asthma, and that every effort to optimise adhe-
rence to ICS maintenance therapy is worthwhile.
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It is interesting to explore potential reasons why the parental medication beliefs and 
the high adherence rates in our study population differed from those previously re-
ported. Selective enrolment of  parents with high need and low concern scores should 
be considered. However, we feel that this is unlikely, because consecutive outpatients 
at our clinic were approached for the study, the large majority of  whom were enrolled 
(figure 1). Furthermore, the high need scores for ICS in this study are in agreement 
with a previous qualitative study from our clinic, in which parents accepted that their 
child needed ICS to control asthma, although parents universally expressed reservati-
ons about having to give daily medication to their child. Parents whose children were 
treated in primary care, however, expressed beliefs of  the high concern-low need pat-
tern. These findings prompted us to hypothesise that parental medication beliefs can 
be modified by repeated tailored education and close follow-up in a specialized asthma 
clinic, resulting in high adherence.26
The young age of  the children in our study may have increased the likelihood of  good 
adherence, because most medication in this age range is given by the parents. Howe-
ver, previous studies have shown poor adherence rates to inhaled medication in young 
children with asthma, even when parents knew that adherence was being monitored.14 
Therefore, parental awareness of  monitoring adherence does not seem a likely cause 
of  the high adherence rates observed. This is supported by the finding that adherence 
rates did not deteriorate significantly over time in our study. Further follow-up of  this 
cohort will allow us to examine whether the high adherence rates observed can be 
maintained over longer periods of  time. 
It should also be noted that access to health care and ICS medication is available to all 
Dutch citizens, because health insurance is mandatory in the Netherlands. Studies in 
urban US populations have shown that poor insurance and financial issues may play a 
major role in poor adherence in such populations.1,6 Although it is conceivable that ex-
cellent insurance coverage may have improved adherence in our study, poor adherence 
has been shown in earlier Dutch studies of  asthmatic children, suggesting that this is 
not a major determinant.4,26 
In the absence of  other logical explanations for the high adherence and constructive 
parental medication beliefs observed, we hypothesise that the organisation of  our 
asthma care may be a contributing factor. The fact that our clinic is run by paediatric 
asthma specialists may be of  importance in that respect. Previous studies have shown 
superior asthma control, better lung function and higher adherence to treatment 
and self-management plans when asthma care was provided by specialist physicians 
(paediatric allergists or paediatric pulmonologists, depending on country and setting) 
compared by general paediatricians or family physicians.3,27,28 A recent systematic 
review showed that more intensive follow-up, with multiple educational sessions using 
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combinations of  instructional modalities, was associated with higher adherence and 
improved outcomes for children with asthma.3 In our clinic, such a comprehensive 
asthma management consists of  frequent follow-up visits to both asthma specialist 
physicians and dedicated asthma nurses, providing repeated tailored education to pa-
rents and patients, and extensively training and checking correct inhalation technique.16 
In earlier studies, we reported the added value of  easy accessibility of  asthma nurses 
which was highly appreciated by parents of  children with asthma.26,29 This was recently 
confirmed in a study from a referral centre for children with difficult-to-treat asthma, 
where the important role of  nurse-led home visits to address parental perceptions, 
contextual and psychosocial issues was highlighted.30 Taken together, these results 
suggest that intensive multi-disciplinary education about self-management, along with 
close follow-up in a specialised clinic setting, helps to improve adherence to ICS in 
children with asthma, with parental perceptions about medication being an important 
mediator.
It should be stressed, however, that a causal relationship between our model of  care 
and the high adherence we observed cannot be established based on our data because 
this was an observational study. Ideally, a randomized controlled trial should be per-
formed to test the hypothesis that comprehensive asthma management and close fol-
low-up, as described, leads to high adherence to maintenance medication. However, it 
has been argued that randomized trials on the effects of  complex interventions, such 
as our model of  asthma management, are fraught with difficulties.16 A prospective stu-
dy in which both adherence and parental perceptions about medicines are followed-up 
over longer periods of  time from the time of  referral to a specialised asthma clinic 
would also be worthwhile.
Strengths and limitations
The main strengths of  our study include the objective, validated, quantitative assess-
ment of  adherence over a considerable period of  time, and the extensive characteriza-
tion of  patients’ and parents’ characteristics using validated methodology. The real-life 
setting avoids any adherence-improving effects of  clinical trial interventions, other 
than the potential adherence-improving effect of  participating in a study. This effect is 
an unavoidable drawback of  electronic adherence monitoring.
The most important limitation of  our study lies in its generalisability. We limited our 
study to 3 month adherence in children aged 2-6 yrs in a specialised asthma clinic. 
Further follow-up of  this cohort and additional studies in other settings are needed to 
substantiate our observation that high adherence combined with well-controlled asth-
ma is possible in other patient groups. Recent studies from other groups support the 
idea that more intensive asthma care enhancing patient-provider partnership improves 





This study shows very high 3-month adherence rates to ICS maintenance treatment in 
children aged 2-6 yrs with asthma. This high adherence was associated with improved 
asthma control, and with parental medication perceptions, which are in agreement 
with the chronic illness model of  asthma. We hypothesise that this desirable combina-
tion of  high adherence and constructive parental medication beliefs can be ascribed to 
the organisation and content of  asthma care, with repeated tailored self-management 
training and close follow-up, which helps to build and maintain a strong partnership 
between patients/parents and the medical team.2 Further studies are needed to exa-
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To evaluate general practitioners’ (GPs’) prescribing behaviour 
as a determinant of  persistence with and adherence to inhaled 
corticosteroids (ICS) in children. 
Methods
This was a prospective observational study of  persistence with 
and adherence to ICS followed by a focus group study of  the 
GPs prescribing this treatment. Participants were 134 children 
aged 2–12 years, who had been prescribed ICS in the year befo-
re the study started by their GPs. Main outcome measures were 
patterns and motives of  GPs’ prescribing behaviour and the 
relationship with persistence with and adherence to ICS.
Results
GPs’ prescribing behaviour was characterized by prescribing 
short courses of  ICS to children with various respiratory 
symptoms without follow-up for making a diagnosis of  asthma. 
This was driven by the GPs’ pragmatic approach to deal with 
the large number of  children with respiratory symptoms, and 
by beliefs about ICS which differed from currently available 
evidence. This prescribing behaviour was the main reason why 
68 (51%) children did not persist with the use of  ICS. In child-
ren with persistent use of  ICS and a GP’s advice to use ICS on 
a daily basis, the median (IQR) adherence was 70% (41–84%), 
and was similar for patients with persistent asthma and children 
lacking a diagnosis or symptoms of  asthma.
Conclusion
Inappropriate prescription of  ICS to children by GPs is com-
mon and drives the lack of  persistence with ICS therapy in 
primary care. This finding should be taken into account when 
interpreting data from large prescription database studies. Im-
proving primary healthcare providers’ knowledge and compe-




Childhood asthma guidelines are unanimous in recommending daily inhaled corticos-
teroids (ICS) maintenance treatment only for children with persistent asthma.1-3 Maxi-
mal efficacy of  such treatment can only be achieved by high adherence rates above 
80% of  prescribed dosages and by persistence with this therapy over long periods.4  
To ensure this, close follow-up of  children with asthma is recommended.1-3 
In daily practice, however, both persistence with ICS prescriptions and adherence to 
their daily use is usually poor. Only half  of  the children having received a first pres-
cription of  ICS have an ongoing prescription 1 year later (poor persistence), and adhe-
rence rates to daily ICS use range from 30% to 70% in different studies.5-7 Patients and 
their parents are usually held responsible for the poor persistence and adherence to 
ICS treatment,8, 9 and interventions to enhance medication adherence are focused on 
how health care providers can improve patients’ and their parents’ adherence behavi-
our.10 
In disagreement with childhood asthma management guidelines, most children with 
asthma are not being followed up regularly in primary care,11, 12 and many children with 
an ICS prescription have not been diagnosed with persistent asthma.7, 13 Although the-
se observations suggest that physician’s prescribing behaviour and primary health care 
organization issues also may be important in determining poor persistence with and 
adherence to ICS treatment in children with asthma, this has received little attention 
in the literature to date. In particular, the reasons why primary care physicians choose 
to deviate from their childhood asthma management guideline have not been explored 
to our knowledge. We designed this study to evaluate primary health care providers’ 
prescribing behaviour, both quantitatively and qualitatively, and the role of  this behavi-
our in persistence with and adherence to ICS prescriptions in children with asthma in 
primary care.
METHODS
This was a sequential mixed-methods study, starting with a quantitative study on ICS 
prescriptions and adherence to ICS use in children 2-12 years of  age in primary care, 
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followed by a qualitative study in which general practitioners (GPs) were interviewed 
about the motivation underlying their prescription patterns. 
Participating GPs
 Nineteen GPs in the catchment area of  our hospital, both from rural and urban 
region primary care practices, were willing to participate in the study. GPs who had 
participated in a previous study from our clinic were approached, after which these 
GPs recruited colleagues. The mean age of  the participating GPs was 50 years (range 
35-65 years), and they had been in practice for a mean of  15 years. There were 16 men 
(84%); most GPs (16, 84%) worked in group practices. The six GPs initially approa-
ched because of  their previous participation in a study were known for their interest 
in childhood asthma care, the other GPs did not follow specific courses on the ma-
nagement of  childhood asthma.
Inclusion of  children
 The quantitative part of  our study was a 12-month longitudinal study in which adhe-
rence was measured electronically in children with persistent ICS use. GPs provided 
details of  all 2-year-old to 12-year-old children who had received an ICS prescripti-
on in the last 12 months. These children were eligible for inclusion in our study. We 
excluded children who had been referred to secondary care for respiratory symptoms, 
those with severe comorbidity, and children whose parents had insufficient knowledge 
of  the Dutch language. We approached no more than 20 children per GP to prevent 
overreliance of  study results on GPs with high ICS prescription rates, and included 
only one child per family. Patients who had not used ICS and had had no asthma 
symptoms in the last 6 months, and patients with occasional intermittent ICS use (less 
than 2 weeks/year) were excluded from the 12-month longitudinal study.
Interviews with parents
To obtain a cross-sectional assessment of  ICS prescription patterns in primary care, 
parents who agreed to participate were interviewed in a structured fashion about 
respiratory symptoms, ICS use and bronchodilator use of  their child in the past 12 
months.   
Assessing adherence 
In  patients  with persistent use of  ICS by metered dose inhaler (MDI)/spacer combi-
nation or dry powder inhalator (DPI), adherence was monitored during the 12-month 
longitudinal follow-up study by the Smartinhaler®(MDI) or the SmartDisk® (DPI), 
electronic devices logging date and time of  each ICS actuation.14, 15 Patients were 
excluded from adherence analysis if  their ICS were withdrawn and stopped within 3 
months of  entry into the longitudinal follow-up study. In all other patients, adherence 
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was calculated as the number of  Smartinhaler-recorded or SmartDisk-recorded inha-
led doses expressed as a percentage of  the number of  doses prescribed, and censored 
at 100% of  the prescribed dose.15 At the end of  the 1-year follow-up study, respiratory 
symptoms were recorded by validated questionnaire,16 supplemented with parental in-
formation about doctor’s prescription of  ICS and bronchodilators, and about the GP’s 
advice on how to use these medications. Data on follow-up visits and organisation of  
asthma care were obtained by chart review. 
Interviews with GPs 
After completing the 1-year follow-up in all the patients, the aggregated adherence 
results and data on follow-up and organisation of  asthma care were discussed in a 2.5 
h focus group interview to which all participating GPs were invited, eight of  whom 
(representing all primary practices involved in the study, mean age 54 years, range 
39–65 years) participated.
Patterns of  prescription of  asthma medication to children and deviations from 
the primary care childhood asthma practice guideline were discussed. Reasons and 
motives for this behaviour were explored in a non-judgmental manner, along with 
a discussion of  perceived advantages and drawbacks of  the GPs’ prescribing beha-
viour. This interview was audio recorded and analysed using standard methods of  
qualitative studies, as in earlier work from our group.17 At the end of  the focus group 
interview, a theoretical framework of  the views discussed was developed by the senior 
researcher based on a recapitulation of  the main findings, which was discussed and 
modified through discussion with all participating GPs until everyone present agreed 
with the final framework. The transcript was charted according to this theoretical 
framework, focused on detection of  quotations not supporting the original framework 
or providing new categories or themes. The five themes that emerged from the date 
comprised: ‘bridge a period with symptoms’, ‘difficulties in establishing a diagnosis of  
asthma’, ‘a pragmatical way of  working’, ‘organisational issues’, and ‘perceptions about 
asthma and ICS’. The final interpretation of  the data and the analysis of  their possible 
explanations were checked by one of  the attending GPs.
Ethical considerations




Patient recruitment is presented in figure 1. The 19 GPs had a mean of  11 (range 
3-28) patients between 2 and 12 years of  age who had received a prescription of  ICS 
in the last year, had no severe comorbidity and had never been referred to secondary 
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care. Of  the 165 eligible children, parents of  12 children could not be reached by 
telephone and 19 declined participation, leaving a total of  134 children whose parents 
provided information about ICS use. Only 66 of  these children (49%) fulfilled the cri-
teria of  persistent ICS use. Their adherence to ICS maintenance therapy was measured 
electronically for 1 year.
Figure 1. inclusion of patients
281 children with ICS 
prescription
Exclusion of 116 children:
- 67 children referred to secondary care 
- 30 children exceeding number of 20    
  patients per GP
- 11 siblings of children included previously 
- 5 children with severe comorbidity
- 3 children using ICS not compatible with 
  Smartinhaler®
165 eligible children 
Parents of 12 children not reached by 
telephone
Parents of 153 children 
reached by telephone
Parents of 19 children declined 
participation
Information about ICS use 
of 134 children (table 1)
Exclusion of 68 children without persistent 
use of ICS
66 children included in 1 yr 
follow-up study
7 children lost to follow up:
- ICS withdrawn
- referred to secondary care
- technical failure of monitoring device
Adherence measured for 1 
yr in 59 children (table 2)
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years of age 
(n=47)
Non-persistent use
Use of ICS only in periods with symptoms (as prescribed by GP, 
for various respiratory symptoms), > 6 months no symptoms 43 (32%) 24 (51%)
Short course of ICS once in first wheezing episode 14 (11%) 6 (13%)
Daily use of ICS stopped at GP’s advice because of remission of 
symptoms
11 (8%) 6 (13%)
Persistent use
Persistent use in children 66 (49%) 11 (23%
Result of  interviews with parents of  children being prescribed ICS
Of  the 134 patients (median age 5.7; IQR 4.0 to 9.8 yrs) whose parents were inter-
viewed, ICS were stopped completely or used during less than 2 weeks per year in 68 
(51%). Parents of  43 (63%) of  these patients with non-persistence with ICS reported 
that they had been using ICS in short courses at the GP’s advice, and 14 of  these 
parents (21%) reported that their child had been using only one single course of  ICS 
ever (table 1). Parents of  21 children (31%) reported chronic cough as the main symp-
tom of  their child; 18 parents (26%) reported that their child had never been prescri-
bed a bronchodilator. Three children had been using ICS for episodes of  croup.
Symptoms and medication use during 1-yr follow-up
Of  the 59 children (median age 7.3, IQR 5-10.8 years) completing the 1-year adheren-
ce monitoring period, 26 (45%) never received a diagnosis of  asthma, according to the 
parents (table 2). Based on parental report and chart review, 15 (26%) and 11 patients 
(19%) had never wheezed or suffered from breathlessness, respectively, and parents 
of  10 patients (17%) reported that ICS had been prescribed for persistent cough. 
During the 1-yr follow-up period, 13 children (22%) remained completely free from 
wheezing or breathlessness. Bronchodilators had never been prescribed to 6 patients 
(10%); 8 others (14%) had been recommended to use their bronchodilator on a daily 
basis (table 2). Although older children more frequently had a diagnosis of  asthma 
(56% vs 21%, p=0.008) and were more often advised to use ICS regularly (78% vs 
43%, p=0.001), differences between age groups in reported symptoms supporting an 














ce for children 
advised to use 
ICS on a daily 
basis (IQR)
GP’s advice use ICS daily 46 (78%) 6 (43%) 70% (41-84%)
use ICS in symptomatic 




never wheezing 15 (25%) 4 (28%) 70% (31-82%)
never breathlessness 11 (19%) 3 (21%) 66% (53-81%)
ICS as treatment for 
persistent cough
10 (17%) 5 (36%) 71% (60-85%)
no GP diagnosis of asthma 26 (44%) 11 (79%) 67% (22-85%)
Frequency of whee-
zing/breathlessness 
in patients ever 
wheezing and/or 
breathless
this year no symptoms 13 (22%) 5 (36%) 61% (54-87%)
this year 1-3 periods 
with symptoms
25 (42%) 5 (36%) 70% (30-81%)
this year >3 periods 
with symptoms
21 (36%) 4 (28%) 73% (26-87%)
Use of 
bronchodilator 
used daily 8 (14%) 1 (7%) 76% (52-87%)
never prescribed, never used 6 (10%) 4 (28%) 77% (70-86%)
Determinants of  adherence during 1-yr follow-up
During the 1-year follow-up, electronic adherence measurements were collected for a 
median (IQR) of  238 (121-350) days. Missing days were caused by children stopping 
ICS at their GP’s advice during a “good” season with little symptoms, children in 
whom ICS therapy was stopped altogether because of  clinical remission, and by tech-
nical device failures. Parents of  13 patients reported that their GP had recommended 
using ICS episodically when the child was symptomatic, but parents of  four of  these 
children administered ICS to their child on more than 50% of  days. 
In the 46 children who were prescribed long-term daily ICS, the median (IQR) ad-
herence rate was 70% (41-84%); 32 children (70%) had adherence rates below 80%. 
Adherence was not determined by the presence of  symptoms supporting an asthma 
diagnosis or by frequency of  symptoms (table 2). 
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Focus group interview with GPs
All GPs recognized the poor persistence with ICS and intermittent use of  ICS as 
representative patterns of  their prescription behaviour. As a general rule, they would 
prescribe a short ICS course to children with respiratory symptoms ranging from 
obvious wheezing and breathlessness to mild wheezing or persistent cough. Prescrip-
tion of  ICS in this way was accompanied by instruction to parents to return with their 
child after 6 weeks if  symptoms persisted (which rarely occurred), or to stop ICS if  
symptoms resolved. GPs explained this prescription behaviour as a practical strategy 
to manage children with a range of  respiratory symptoms without having to focus on 
making or excluding specific diagnoses. 
GP 3: “It is not a conscious process; it is determined by the way we work.”
For children with symptoms likely to be self-limiting, such as chronic cough, the main 
reason for ICS prescription was to ‘bridge a period with symptoms’. In particular 
when parents were expecting or demanding a therapy, this strategy was used. In the 
GPs’ opinion, this satisfied most parents and prevented lengthy discussions about 
the lack of  effective treatment options for cough, and about the need for referral to 
secondary care. 
GP 4: “Parents and children are satisfied, that’s great. The diagnosis doesn’t really 
matter.”
GP 1: “I sometimes think back to the good old days when we were still allowed to use 
oral anticholinergics to help bridge a period of  symptoms”
If  symptoms returned in children with more obvious wheezing disorders, parents 
were encouraged to start another short ICS course themselves or the GP would pre-
scribe it once again. Although GPs realized that they did not follow-up these patients 
or evaluated treatment effect, many considered these repeated ICS bursts as serial 
‘treatment trials’, building up to an eventual asthma diagnosis in some children. Most 
GPs expressed lack of  confidence in their ability to diagnose asthma, particularly in 
young children.
GP 8: “It is symptom treatment, really. On and off, you know, without thinking about 
a diagnosis”
GP 5: “A diagnosis of  asthma is rarely made by me; I guess this happens mainly in 
secondary care. They have better diagnostic tools there, like lung function”
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Besides the two main reasons for prescribing short courses of  ICS (bridging a period 
of  symptoms and working on establishing a diagnosis of  asthma), GPs expressed ad-
ditional perceptions about ICS and asthma that supported their prescribing behaviour. 
Most GPs viewed a 6-week course of  ICS as an effective treatment option for child-
ren with chronic cough or intermittent wheezing. For some GPs this view was driven 
by their perception that these symptoms could be presenting symptoms of  asthma. 
GP 6: “Cough is also an expression of  inflammation, which ICS may help to control.”
This prescribing behaviour was also driven by the GPs’ desire not to undertreat asth-
ma. In their opinion the pros of  this approach (not undertreating asthma) outweighed 
the cons (overtreatment of  nonspecific cough and mild intermittent wheezing with 
ICS), because they viewed short ICS courses as harmless. They remarked that the re-
active organization of  primary health care for children (i.e., seeing the child only when 
symptoms occurred) instead of  being proactive (with scheduled follow-up) enhanced 
this prescribing behaviour.
GP 3: “Most important lesson of  this study for me? Making asthma care more proac-
tive!”
DISCUSSION
This study shows a common practice of  prescribing short courses of  ICS to children 
with various respiratory symptoms in primary care. This prescribing behaviour, which 
deviates from primary care childhood asthma management guidelines, is driven by a 
pragmatic approach aimed at symptom-treatment rather than making or excluding the 
diagnosis of  asthma, and is enhanced by the reactive organization of  primary care, 
where children are mainly being seen when symptoms occur, instead of  being follo-
wed up regularly. Many GPs expressed perceptions about ICS and asthma which are 
in disagreement with the currently available evidence, stimulating the overtreatment 
of  children with nonspecific or mild intermittent respiratory symptoms. The very low 
persistence with ICS in children is largely explained by this prescribing behaviour. Of  
the 59 children with persistent use of  ICS, 20% used ICS only during symptomatic 
episodes (at the GP’s advice) and a similar proportion had no asthmatic symptoms 
ever but used ICS on a daily basis. Children with persistent wheeze were also com-
monly treated with intermittent courses of  ICS.  
The high ICS prescription rates in children without persistent asthma and low persis-
tence with ICS that we found confirm results from previous studies in various coun-
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tries. In two Dutch primary care studies, ICS were frequently prescribed to children 
and adults without a diagnosis of  persistent asthma, and ICS persistence over a 1-yr 
follow-up period was only 50%.7,18 In a large Dutch birth cohort study, 36% of  child-
ren 2-8 years of  age used ICS without having reported a single episode of  wheezing 
in the past two years.19 Several UK studies also reported high ICS prescription rates 
to children without persistent asthma, but with intermittent wheeze or chronic cough, 
together with low persistence with ICS therapy.4, 13, 20 A recent Swedish study reported 
the same pattern of  poor persistence with ICS, although the authors did not consider 
liberal ICS prescription by physicians.21 Although it has been speculated that low ICS 
persistence rates could be explained by the use of  ICS as a diagnostic treatment trial in 
children with nonspecific respiratory symptoms, previous studies never examined the 
reasons for ICS prescription behaviour of  GPs. 
Our focus group interview with GPs now provides unique and innovative insights 
into the pragmatic way in which GPs deal with the large number of  children pre-
senting with various respiratory symptoms. In agreement with our results, previous 
studies reported that primary care paediatricians in the USA and Spain recommended 
short-course ICS therapy for fictional patients with asthma, virus-induced wheeze, 
and bronchiolitis.22-24 In these studies, primary care physicians with limited experience 
in respiratory disorders were most likely to show this erratic prescribing behaviour. 
Our study indicates that such limited experience is associated with lack of  confiden-
ce in making or excluding a diagnosis of  asthma, particularly in young children, and 
with non-evidence based perceptions about the effects of  short-course ICS therapy 
on cough and on mild intermittent wheezing, confirming findings from a previous 
study.25
 
Because establishing the diagnosis of  asthma may indeed be difficult, in particular 
in young children,26 and because most respiratory symptoms in young children are 
transient, the pragmatic approach of  GPs to treat nonspecific respiratory symptoms 
with short courses of  ICS is understandable, particularly when considering their view 
that short ICS courses are harmless and their desire not to undertreat asthma. Nevert-
heless, there are numerous reasons to discourage this practice. First, even though most 
of  these children inappropriately being prescribed ICS used the medication only brie-
fly, some of  these children were unnecessarily exposed to daily ICS for long periods 
of  time, increasing the risk of  exposure to high doses of  ICS and their associated side 
effects.27 Second, under this regime, children with asthma were also treated intermit-
tently with ICS instead of  the recommended daily use.1-3 Third, inappropriate ICS 
treatment may distract from appropriately diagnosing and treating the real cause of  
their respiratory symptoms, such as a lower respiratory tract infection or allergic rhini-
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tis.28 Fourth, prescribing ICS to satisfy parents and to avoid lengthy discussions about 
referral or the lack of  effective treatment for cough, although helpful in running an ef-
ficient clinic in the short term, may jeopardize a constructive physician-patient-parent 
relationship in future consultations. Finally, unnecessary ICS treatment for nonspecific 
cough generates considerable societal costs (an estimated €1 million per annum in our 
country of  17 million inhabitants).
Our study has considerable implications both for research and for clinical practice. 
ICS persistence and adherence studies are usually based on large pharmacy databases, 
with limited information about physician’s considerations, beliefs, and prescribing 
practices. Such studies rely heavily on appropriate diagnosing and prescribing behavi-
our of  physicians, while our study illustrates how important it is to take the physicians’ 
prescribing behaviour into account to interpret and understand these data. The GPs 
in our study acknowledged the problem of  lacking proactively organized primary care 
for children with respiratory symptoms, and suggested using specialized nurses as an 
important solution to ensure scheduled follow-up for these patients. Previous studies 
from our group have shown that children with a confirmed diagnosis of  asthma can 
effectively and cost-efficiently be followed up by asthma nurses.29 The GPs themsel-
ves, however, are responsible for solving the problem of  inappropriately prescribing 
ICS to children without persistent asthma and advising short courses of  ICS to child-
ren with asthma. The presence of  erratic perceptions suggests the need for additional 
targeted training in asthma diagnosis and management for GPs. Such training has 
been shown to be effective in improving asthma care to children.30 
Strengths and limitations
The main strength of  this study is that we collected detailed information about the 
patients’ symptoms and ICS use, and on the reasons and motivations for GPs’ pre-
scribing behaviour, which not only highlighted important areas for improvement in 
primary care for children with asthma, but also provided a novel explanation for the 
previously described poor ICS persistence in children. The main limitation is the 
generalizability of  this study because we studied only GPs willing to participate in the 
study of  which a number with specific interest to childhood asthma care.  Because 
of  this interest of  these GPs, it is not likely other GPs perform better in prescribing 
ICS and following asthma guidelines. Considering the similarities of  our findings with 
previous reports of  prescribing patterns of  ICS in primary care in several countries,5, 7, 
13, 20-24 we believe our findings can be applied to most settings of  primary care.
A second limitation is recall bias because parental report of  asthmatic symptoms in 
their children was recorded retrospectively, at the end of  the follow-up period. Ho-
wever, because the questionnaire we used for this purpose was validated and has been 
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used extensively in previous work, it is unlikely that this had a major influence on our 
findings.16, 19 
CONCLUSION
 Inappropriate prescription of  ICS to children by GPs is common and is driven by a 
pragmatic approach to treat symptoms rather than making or excluding a diagnosis of  
asthma, erratic perceptions about the efficacy of  ICS in reducing persistent cough and 
mild intermittent wheeze, and a reactive organisation of  primary care where scheduled 
follow-up is exceptional. The inappropriate prescribing behaviour of  GPs that we ob-
served drives the lack of  persistence with ICS therapy in primary care and this finding 
should be taken into account when interpreting data from large prescription database 
studies. The large number of  inappropriate ICS prescriptions together with intermit-
tent therapy in children with asthma stresses the need to improve GPs’ knowledge and 
competence in diagnosing and managing asthma in children in primary care.
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To study patient- and physician-related determinants of  1-year 
electronically measured adherence to inhaled corticosteroids in 
children with asthma in primary and secondary care. 
Methods
This was an observational study with one year follow-up in 
a hospital-based outpatient clinic providing comprehensive 
asthma care and seven primary care practices providing ba-
sic asthma care. Participants were children 2-12 years of  age 
with asthma and a prescription of  inhaled corticosteroids. 
Long-term adherence to inhaled corticosteroids was electroni-
cally measured. A broad range of  putative determinants were 
assessed, including parental illness perceptions and medication 
beliefs, and patient-centeredness of  consultations, by validated 
questionnaires.
Results
Median (interquartile range) adherence was significantly higher 
in secondary (84%, 70 to 92%) than in primary care (66%, 
32 to 86%, p<0.001). Parents from secondary care expressed 
higher ICS need for their child; they also rated patient-cente-
redness of  consultations higher than parents in primary care. 
The relationship of  these findings and the level of  asthma care 
was potentially biased by less severe asthma in children from 
primary care, but children from primary care and secondary 
care had similar high median rates of  asthma control. 
Conclusion
Patient-centred, guideline based comprehensive asthma care 
with repeated scheduled follow-up is associated with considera-
bly higher adherence than basic asthma care with single-session 
education and lack of  scheduled follow-up. Modification of  
parental medication beliefs appears to be an important modera-
tor of  this association. Improvement of  asthma care can make 
a pivotal contribution to improving adherence and reducing the 




Adherence to daily medication is of  critical importance in determining the success 
of  treating chronic conditions such as childhood asthma.1 Poor adherence to mainte-
nance medication is the rule rather than the exception, however.1 Knowledge of  the 
reasons for such poor adherence may help to improve adherence, and the effects of  
treatment. 
The most basic form of  non-adherence is when patients (and their parents, if  the 
patient is a child) do not understand the rationale for treatment (unwitting non-adhe-
rence).2 Although this can be easily overcome by providing appropriate information, 
studies consistently show that education alone is insufficient to improve adherence, 
indicating that other factors are more important in driving non-adherence.3 These can 
be divided into two groups. First, unplanned non-adherence is related to limited family 
(medicine taking) routines, and child raising issues.2, 4 Second, intentional non-adheren-
ce refers to patients who deliberately choose not to follow the doctor’s recommenda-
tions, based on their illness perceptions and medication beliefs.2 Such perceptions and 
beliefs have consistently been shown to be strong determinants of  adherence.5, 6
Currently available research on non-adherence has primarily examined patient related 
factors.1 Accumulating evidence, however, shows that the organization of  health care 
and the health care provider’s behaviour have major impact on adherence in a range 
of  chronic conditions.1, 7-9 Children from underprivileged backgrounds exposed to 
numerous risk factors for non-adherence can achieve good adherence and asthma 
control when enrolled in a programme of  self-management education and close fol-
low-up.10  Such a programme of  comprehensive self-management education and fol-
low-up, while common in hospital-based secondary care, is rare in primary care.11-14 In 
a recent  qualitative study, we observed considerable differences in illness perceptions 
and medication beliefs between parents of  asthmatic children in primary and secon-
dary care, suggesting that comprehensive care allows modification of  these impor-
tant determinants of  adherence.14 In the present longitudinal observational study, we 
monitored adherence and its patient- and physician-related determinants in patients in 




Design and setting. This was an observational study with one year follow-up of  ast-
hmatic children aged 2-12 years, receiving asthma care in our hospital-based outpa-
tient clinic (with comprehensive asthma education and close follow-up, as described 
previously)15 or in one of  seven participating primary care practices in the catchment 
area of  our hospital (with mostly single-session education and follow-up as needed by 
patients and parents).14 
Inclusion
In primary care, general practitioners provided a list of  all 2-12 year old children who 
had received an ICS prescription in the last 12 months. Children who had ever been 
referred to secondary care for their asthma were excluded, and the number of  patients 
per GP was limited to 20. Parents of  all other children were approached by telephone 
(as described previously).16 Children were eligible for inclusion in the 1-yr follow-up 
study if  they had persistent ICS use. This was defined as parents reporting having 
received the advice (from their GP) to give ICS to their child on a daily basis, having 
indeed been using the ICS during the last 6 months for recurrent wheezing and bre-
athlessness (not isolated cough), and expecting to continue using ICS during the next 
three months.
In secondary care, parents of  all children aged 2-12 years with paediatrician-diagnosed 
asthma and persistent ICS use attending the outpatient clinic for regular follow-up 
were asked to participate in the study. Only one child per family was included. Exclu-
sion criteria comprised limited knowledge of  the Dutch language and severe comorbi-
dity.
Follow- up and assessment of  adherence to ICS
Throughout the 12-months follow-up, adherence was monitored by electronic devices 
logging date and time of  each ICS actuation: Smartinhaler® for metered dose inhaler 
(MDI)/spacer combination, SmartTracker® for MDI with dose counter, and Smart-
Disk® for Diskus/Accuhaler.15, 17 At each follow-up visit , or during home visits when 
time to the next scheduled follow-up visit exceeded 5 months, data recorded by the 
electronic devices where uploaded and proper recording function checked. Adherence 
was calculated as the number of  electronically recorded inhaled doses expressed as a 
percentage of  the number of  doses prescribed, censored at 100% of  the prescribed 
dose.4 
Putative determinants of  adherence
We collected clinical and demographic data by structured interview and chart review. 
Upon entry into the study, a number of  validated questionnaires were administered 
to parents and children. Parental illness perceptions were assessed by the Brief  Illness 
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Perception Questionnaire (B-IPQ),18 and medication perceptions by the Beliefs about 
Medicines Questionnaire (BMQ, which also provides the balance between parent-per-
ceived necessity and concerns about ICS)19 , and the Treatment Satisfaction Questi-
onnaire for Medication (TSQM).20 In addition, we applied the ‘I Worry scale’ (scoring 
parental worries about their child having asthma and using daily ICS),21 the Satisfac-
tion with Information about Medicines Scale (SIMS),22 and an asthma knowledge 
questionnaire.
At baseline and at 6 and 12 months follow-up, asthma control and parental quality of  
life were assessed by parent-completed Asthma Control Questionnaire (ACQ) and the 
Paediatric Asthma Caregiver Quality Of  Life questionnaire (PACQOL), respectively.23,24
Participating children aged 8-12 years completed children’s versions of  each question-
naire, without input from their parents, under supervision by the investigator (TK). 
At the end of  1-yr follow-up, we asked the parents to assess the degree of  patient 
centeredness the physician had employed during the study period with a questionnaire 
focusing on physician’s exploration of  parental views and concerns about the illness 
and the medication and on achieving mutual agreement about treatment.25
Analysis 
We assessed the association of  ICS adherence to all putative determinants (defined a 
priori with a focus on parental perceptions about illness and medication) for primary 
care and secondary care separately, and for the total population, in nonparametric 
univariate analyses (because of  skewed distribution of  adherence) using SPSS version 
17.0. We chose to refrain from adjustments for multiple comparisons and from multi-
variate analysis because of  the exploratory and observational nature of  our study.
RESULTS
Patient recruitment and follow-up
Inclusion in primary care was hampered by lack of  persistent ICS use: 50% of  the 
children who had had an ICS prescription during the last 12 months had not been 
using ICS in the last 6 months (figure 1).16 In primary care and secondary care, 42 
children (86% of  those enrolled) and 135 children (90% of  those enrolled) comple-
ted the study, respectively. Of  these children, 167 (94%) were followed for 1 year, 10 
children were followed-up until medication was stopped by the physician after at least 
3 months participation in the study (figure 1). 
Electronic adherence data were collected for a median of  286 days (interquartile range 
152-362 days).  Reasons for missing data included technical failure of  the electro-
nic monitoring devices, parents not bringing back the devices or returning damaged 




f igure 1. Inclusion of patients (part 1 of 2)
Primary Care
281 children with ICS 
prescription
Exclusion of 116 children:
- 67 children referred to secondary care 
- 30 children exceeding number of 20 
patients per GP
- 11 siblings of children included previously 
- 5 children with severe comorbidity
- 3 children using ICS not compatible with   
  adherence logger
165 eligible children 
Parents of 12 children not reached by 
telephone
Parents of 153 children 
reached by telephone
Parents of 19 children declined 
participation
Information about ICS use 
of 134 children
Exclusion of 85 children without persistent 
asthma or persistent use of ICS
49 children included in 1 yr 
follow-up study
7 children lost to follow up:
- ICS withdrawn before 3 month follow-up
- referred to secondary care
- technical failure of monitoring device




Parents of 44 children declined 
participation
Parents of 7 children had limited 
knowledge of Dutch language
Secondary Care
232 visiting outpatient 
asthma clinic
Exclusion of 30 children:
- 4 siblings of children included previously 
- 8 children with severe comorbidity
- 18 children using ICS not compatible with 
   adherence logger
202 eligible children
Parents of 198 children 
reached by telephone
147 children included in 
1 yr follow-up study
Follow-up of 135 
children
Parents of 4 children not reached by 
telephone
12 children lost to follow up:
- ICS withdrawn before 3 month follow-up
- moved to other area
- technical failure of monitoring device
- parents stopped participation
- parents deceased
figure 1. Inclusion of patients (part 2 of 2)
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Differences between participants in primary and in secondary care
Children from primary care were older, used a lower daily ICS dose, had slightly 
better quality of  life, and had been less frequently hospitalized before study entry than 
children from secondary care (table 1). Asthma control as assessed by ACQ was com-
parable, with good asthma control at baseline and throughout 1-yr follow-up in most 
children (table 1). Parental quality of  life remained high in both groups throughout the 
study. In primary care, patients were seen less frequently for follow-up, parents were 
less satisfied with the information about medicines, and physicians’ patient-centered-
ness was rated lower than in secondary care (table 1). 
Differences in parental illness perceptions and medication beliefs between primary and secondary care 
Parents from secondary care perceived higher influence of  asthma on their child 
(p=0.038) and reported higher levels of  concerns (p=0.002) and emotions (p=<0.001) 
regarding their child’s asthma. The maximum difference in the mean scores of  illness 
perceptions (score 1 to 10) was 2 points. Parental perceived ICS necessity was signifi-
cantly higher in secondary care, where ICS concerns superseded necessity in only 12 
parents (9%) , as compared to 10 parents (26%) in primary care (p<0.001). 
Adherence rates in primary and secondary care
Adherence was considerably higher in secondary than in primary care (figure 2), with 
median (interquartile range, IQR) adherence of  84% (70-92%) and 66% (32% to 86 
%), respectively (p<0.001). The proportion of  children with adherence > 80% of  
Figure 2. Electronically measured adherence in primary care and secondary care.
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Age (mean; range; yrs) 8 (2 to 12)  6 (2 to 12) <0.001
Maintenance -inhaled corticosteroids (ICS) 100% 90% 0.065
medication: -ICS and long-acting 
bronchodilators (%)
0% 10%
-ICS dose (fluticasone®; mean; 
range; μg)
175 (50 to 250) 250 (125-500) 0.014
Nr of children hospitalised in year 
before study (%)
2 (5%) 37 (27%) 0.004
Nr of children requiring prednisolone for asth-
ma exacerbations
4 (10%) 25 (19%) 0.256
ACQ baseline (<0.75 = well-controlled asthma, 
>1.5 = not well-controlled asthma)
0.67 (0.33 to 
1.13)
0.50 (0.17 to 1.17) 0.498
ACQ at 6 months 0.67 (0.00-1.34) 0.33 (0.00-1.00) 0.303
ACQ at 12 months 0.50 (0.00-0.83) 0.50 (0.00-1.17) 0.551
Parents
Educational level of mother 
(1 = low and 7 = high) 
5 (4 to 7) 5 (5 to 6) 0.823
Parental diagnosis of asthma 40% 40% 0.932
PACQOL (1 = low and 7 = high quality of life) 6.7 (6.1 to 6.9) 6.3 (5.5 to 6.9) 0.008
PACQOL at 6 months 6.7 (6.4-7) 6.7 (6.1-6.9) 0.129
PACQOL at 12 months 6.9 (6.4-7.0) 6.7 (6.3-6.9) 0.062
Asthma care
Number of visits to GP or outpatient clinic in 
study year (range)
1 (0 to 3) 4 (2 to 4) <0.001
SIMS (0 = low and 9 = high level of satisfaction) 8 (6 to 9) 9 (7 to 9)  0.024
Patient-centeredness questionnaire 
(1 = low and 5 = high) 
3.1 (2.9 to 4.0) 4.0 (3.4 to 4.6) <0.001
Data are presented as mean ± SD, or as median (interquartile range) unless otherwise stated; 
ACQ: Asthma Control Questionnaire; PACQOL: paediatric asthma caregiver quality of life ques-
tionnaire; SIMS: Satisfaction with Information about Medicines Scale.22-24
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Table 2. Determinants that showed statistically significant correlation with adherence
Rank correlation coefficient between independent 







ρ p-value ρ p-value ρ p-value
Characteristics of children
Child’s age -0.27 0.086 -0.15 0.082 -0.23 0.002
ACQ at 6 months -0.19 0.247 -0.21 0.020 -0.23 0.004
ACQ at 12 months 0.12 0.503 -0.23 0.016 -0.13 0.128
TSQM, children’s global satisfaction of 
daily use of ICS (n=28)
NA 0.51 0.006 NA
Characteristics of parents
Educational level mother 0.16 0.354 0.17 0.060 0.15 0.046
Characteristics of care
Parental asthma knowledge 
questionnaire
0.39 0.012 0.08 0.380 0.17 0.027
Patient-centeredness 
questionnaire
0.43 0.008 0.01 0.948 0.18 0.035
Parental perceptions about illness & medication
BMQ, specific part, subscale 
necessity of ICS
0.40 0.012 0.07 0.437 0.20 0.009
BMQ, specific part, 
need-concern ratio
0.29 0.070 0.08 0.355 0.15 0.045
BMQ, perceptions about harm and over-
use of medication in general
-0.13 0.421 -0.18 0.041 -0.16 0.038
TSQM, subscale convenience of daily 
use of ICS
0.20 0.212 0.26 0.003 0.23 0.003
TSQM, subscale global satisfaction of 
daily use of ICS
0.29 0.074 0.17 0.059 0.19 0.011
B-IPQ, emotional response on child’s 
asthma 
0.03 0.843 0.06 0.484 0.15 0.047
B-IPQ, feeling of understanding child’s 
asthma
-0.27 0.090 -0.12 0.159 -0.19 0.013
#: in all items higher scores  represent higher level of measured concepts, with the exception 
of Asthma Control Questionnaire in which high scores represent poor asthma control; ACQ: As-
thma Control Questionnaire; TSQM: Treatment satisfaction questionnaire for medication; BMQ: 
Beliefs about Medicines Questionnaire; B-IPQ: Brief Illness Perception Questionnaire.18-20, 23
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prescribed doses was 29% in primary and 59% in secondary care (p=0.001); the medi-
an (IQR) number of  days on which children received no ICS was 17% (4% to 49%) in 
primary and 6% (1%-19%) in secondary care (p=0.004).
Determinants of  adherence
Determinants significantly associated to adherence differed between primary and 
secondary care (table 2). In primary, but not in secondary care, asthma knowledge, ICS 
necessity, and patient-centeredness were strong determinants of  adherence. In both 
groups, parents who viewed ICS administration as convenient, who reported high 
global satisfaction with ICS, and who expected little harm of  medicines in general 
had higher ICS adherence rates (table 2). The only factor significantly associated with 
adherence from the children-completed questionnaires was global satisfaction with 
ICS therapy (table 2).
DISCUSSION
This study shows that adherence to daily ICS use in children with asthma was con-
siderably lower in patients followed up in primary care than in secondary care. In 
secondary care, children’s asthma was more severe at study entry than in primary care, 
with more hospitalizations, higher ICS dose, and lower quality of  life. Asthma control 
scores and exacerbation rates, however, were comparable in the two groups throug-
hout follow-up. The higher adherence in secondary care was accompanied by a higher 
parental perceived need of  the daily use of  ICS. Parents rated patient-centeredness 
of  consultations higher in secondary than in primary care. Medication beliefs were 
associated with adherence rates in both settings. In addition, asthma knowledge and 
patient-centeredness were strong determinants of  adherence in primary care. Of  all 
studied modifiable patient-related factors, parental medication beliefs were the only 
determinants of  the measured adherence that differed between primary care and 
secondary care. This suggests that such medication beliefs are the moderator of  the 
relationship of  quality of  asthma care and adherence to ICS. 
Strengths and weaknesses
The main strengths of  this study are the electronic measurement of  adherence, the 
follow-up of  1 year, the comparison between primary and secondary care, and the 
comprehensive collection of  putative determinants of  adherence. The poor persis-
tence with ICS in primary care hampered the inclusion of  children from primary care, 
causing a relatively small study population in this setting. The cross-sectional measure-
ment of  parental illness perceptions and medication beliefs does not allow firm infe-
rence of  causality that these cognitions were modified by comprehensive asthma care. 
An alternative explanation for the observed higher perceived necessity of  ICS in the 
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secondary care group could be differences in asthma severity or the age of  the child-
ren between the two settings. Previous studies, however, have shown poor adherence 
in children with asthma irrespective of  asthma severity, and no association of  asthma 
disease characteristics and adherence.26 It appears unlikely, therefore, that the differen-
ces we observed in medication beliefs and adherence between primary and secondary 
care are caused by selective recruitment of  high-necessity, highly adherent parents in 
secondary care. Similarly, the small difference in age between the populations is too 
small to be responsible for the large difference in adherence we found. 
Comparison to other studies in the field
The strikingly high adherence rate of  the children with asthma in secondary care in 
this study (median 84%) far exceeds that previously reported in long-term quantitative 
adherence studies (40-70%),4, 27-30 which were comparable to the adherence found in 
our primary care group (66%). This is clinically highly relevant because of  the strong 
relationship between adherence and asthma control (table 2).31, 32 These findings 
illustrate that characteristics of  healthcare organization and delivery are important 
determinants of  adherence,1 and that good adherence can be achieved in the large ma-
jority of  children receiving  comprehensive guideline-based asthma care.10, 33 The key 
components of  comprehensive asthma care being delivered by asthma specialists in 
secondary care appear to be regular follow-up and repeated tailored self-management 
education. In contrast, the asthma management in primary care was characterized by 
mostly single-session education and haphazard or absent follow-up. This is not unique 
to our study, as this phenomenon has been reported in several countries in Europe 
and North America.11, 12, 34-36 
International guidelines including the Dutch primary care guideline, however,  recom-
mend regular follow-up and self-management education.37-39  Poor adherence by pri-
mary care professionals to asthma guidelines is therefore common, and is associated 
with poor adherence to maintenance medication by patients and parents in this study. 
In accordance with previous studies,2, 26, 40 parental medication beliefs were the main 
determinant of  non-adherence to ICS (table 2). The significantly higher ICS necessity 
perception in parents in secondary care as compared to those in primary care suggests 
that counterproductive medication beliefs (concerns exceed perceptions of  benefit) 
can be modified into constructive and useful beliefs (benefits outweigh concerns) as 
the result of  comprehensive guideline based asthma care. This is supported by the few 
previous studies which have examined whether illness and medication beliefs can be 
modified.6, 41 This appears to be dependent on whether the health care professional is 
able to explore the patient’s (or parents’) illness perceptions and medication beliefs, 
and is able to build sufficient rapport and trust to discuss these cognitions constructi-
vely,42 aiming at making a shared decision on treatment.43, 44 In a randomized control-
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led trial of  adults with asthma, individualized text messaging, tailored to each patient’s 
specific information based on a discussion of  their illness perceptions and medication 
beliefs, modified these cognitions and improved self-reported adherence.41 Therefore, 
it appears not to be the regular follow-up in itself, but the physician’s communication 
behaviour during follow-up that determines long-term adherence to daily maintenance 
medication in children with asthma.   
Practice and research implications 
The results of  this study have important implications both for clinical practice and 
research. Our findings underscore the need to enhance implementation of  guide-
line-based comprehensive asthma care, with close follow-up and repeated tailored 
self-management education. Children with asthma should be managed in a setting in 
which such care can be guaranteed. This is likely to improve adherence to maintenan-
ce medication, and reduce the burden of  uncontrolled asthma in the community. 
The implications for future adherence research are twofold. Firstly, because of  its 
high level and limited variation, a quantitative study such as ours has limited power in 
detecting the determinants of  adherence in children receiving comprehensive asthma 
care. Unravelling the components of  comprehensive asthma care responsible for high 
adherence, therefore, needs a different, probably qualitative study design. Second, 
prospective studies are needed to study how parents’and children’s illness percepti-
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It’s the adherence, 
stupid! (that determines 










To explore the relationship between adherence to inhaled corti-
costeroids and long-term asthma control in young children with 
asthma.
Methods
Eighty-one 2–6-yr-old asthmatic children, using inhaled 
corticosteroids (ICS), enrolled in a program with extensive 
self-management training and close follow-up were enrolled. 
Adherence was measured daily for 12 months using Smartinha-
ler® devices. Long-term asthma control was assessed by parents 
and physicians and included clinical assessment, asthma control 
questionnaire, and lung function. We examined the association 
of  adherence to short-term and long-term asthma control, 
adjusting for seasonal influences and clinical characteristics.
Results
Median (interquartile range) adherence was 87% (70-94%), 
and 64 (79%) children had well-controlled asthma throughout 
follow-up. Adherence >80% was associated with better asth-
ma control, and we found no important confounders of  this 
association. Children with persistent mild symptoms had lower 
adherence rates (p=0.028).
Conclusion
Guideline-based asthma care was associated with good asthma 
control in most children. Adherence to inhaled corticosteroids 
was an independent strong predictor of  long-term asthma 
control, with highest levels of  asthma control found in children 




Daily low-dose inhaled corticosteroid (ICS) therapy significantly improves asthma 
control, both in school-aged and in pre-school children with persistent asthma.1,2 
Poor adherence to this therapy decreases the effectiveness of  ICS, but studies on the 
relationship of  adherence and asthma control are complicated by the different me-
thods used to assess adherence. Electronic monitoring devices recording date and time 
of  each inhaler actuation have been shown to be the most accurate measurement of  
adherence.3-5 The few studies using this methodology in children showed an increased 
risk of  uncontrolled asthma or an asthma exacerbation in children with lower adhe-
rence over the preceding 1- or 3-month period, respectively.6,7 Although these studies 
therefore show an association between adherence and asthma control at group level 
over short periods of  time, no studies to date have examined the relationship between 
long-term asthma control and adherence in individual patients. A number of  factors 
may influence this relationship over longer periods of  follow-up. First, short-term 
adherence is likely to increase when parents know that adherence is being monitored, 
or when a follow-up visit is approaching, while long-term adherence decreases over 
time.6,8 Secondly, individual characteristics such as significant comorbidity and sea-
sonal changes in asthma control may influence the relationship of  long-term asthma 
control and adherence.9 Thirdly, the focus of  guideline-based comprehensive asthma 
care is not only on adherence, but also on improving inhalation technique, eliminati-
on of  exposure to relevant allergens and irritants (including environmental tobacco 
smoke) and treating comorbidities such as allergic rhinitis, all of  which may contribute 
to improved asthma control.10 Previous studies have shown that such comprehensive 
asthma care with regular follow-up was associated with achieving and maintaining 
well-controlled asthma in inner-city asthmatic children.11,12 Although the authors 
suggested that adherence may explain the relationship between comprehensive asthma 
care and asthma control, adherence in these studies was assessed by health care provi-
ders instead of  being monitored electronically. 
We previously showed very high median electronically measured adherence rates and a 
significant association between adherence and asthma control in 2-6 year old children 
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with persistent asthma followed up at our hospital-based paediatric asthma clinic for 
3 months.13 In the present study, we examined the association between daily electroni-
cally measured adherence and asthma control during 12 months of  follow-up, which 
allowed us to take several potential confounders into account.
 
METHODS
Design and setting 
This was an observational study with one year follow-up of  asthmatic children aged 
2-6 years, who were being monitored and followed up at our hospital-based paediatric 
asthma outpatient clinic. To enter our asthma management program, children have 
to be referred by their primary care practitioner because of  troublesome, severe, or 
frequent symptoms. After the diagnosis of  persistent asthma had been made by the 
attending paediatrician, ICS by metered dose inhaler/ spacer combination were being 
prescribed as daily controller therapy, irrespective of  the wheezing phenotype (episo-
dic viral or multiple trigger wheeze), in accordance with the national paediatric asthma 
guidelines.14 Details of  the asthma management program in our clinic have been pu-
blished previously,13,15 and comprise extensive training of  correct inhalation technique, 
home-visits to assess and reduce exposure to relevant allergens and tobacco smoke 
and treatment of  relevant comorbidities.
Inclusion and collection of  baseline data
For this study, parents of  all children aged 2-6 years with persistent asthma currently 
treated with ICS attending the outpatient clinic for regular follow-up were asked to 
participate in the study. Exclusion criteria comprised limited knowledge of  the Dutch 
language and severe comorbidity. All included children whose ICS were withdrawn 
at the physician’s advice during or immediately after completion of  the study were 
excluded from analysis, because asthma control in these children was considered to 
be unrepresentative because of  clinical asthma remission. We collected demographic 
and clinical data by structured interview and chart review. At baseline, lung function, 
asthma control, and parental quality of  life were also recorded. Lung function was 
assessed before and after inhaling salbutamol 400 µg: flow-volume curves in children 5 
years of  age and older, and respiratory resistance (Rint) by Microrint® in children < 5 
years of  age (Microrint®; Micro Medical Ltd, Rochester, UK) , according to European 
Respiratory Society/American Thoracic Society guidelines.16 Results were expressed as 
Z-scores. Asthma control was assessed by parent-completed Asthma Control Questi-
onnaire (ACQ), and parental quality of  life by the Paediatric Asthma Caregiver Quality 
Of  Life questionnaire (PACQOL).17, 18
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Assessment of  adherence to ICS
Throughout the 12-months follow-up, adherence was monitored by Smartinhaler®, a 
validated electronic device logging date and time of  each ICS actuation.13,19 At each 
follow-up visit to the clinic, the data recorded by the Smartinhaler® where uploaded 
and proper recording function checked. To prevent considerable loss of  data in case 
of  malfunctioning devices and to assess asthma control regularly, a home-visit was 
made by a researcher to upload the Smartinhaler® and record parental assessment of  
asthma control, when time to the next scheduled follow-up visit exceeded 5 months.
Assessment of  asthma control, lung function, and parental quality of  life during follow-up 
At each follow-up visit, asthma control was assessed by the attending physician and 
paediatric asthma nurse on a visual analogue scale ranging from 0 (completely uncon-
trolled asthma) to 10 (completely controlled asthma), based on a review of  symptoms, 
limitations, and exacerbations since the previous visit.20 The prescribed daily dose and 
dosing frequency of  maintenance treatment for asthma and any identified comorbid 
disorder was documented in the patient’s chart at each follow-up visit, and recorded 
for study purposes. At each visit, parents completed an ACQ about their child, and 
reported any exacerbations that had occurred since the previous visit. After 6 and 
12 months of  follow-up, parents also completed the PACQOL, lung function was 
performed as described above, and a single-breath fraction of  nitric oxide in exha-
led breath (FeNO) measurement was carried out with a hand-held electrochemical 
analyser (NIOX Mino; Aerocrine, Solna, Sweden) with an expiration time of  6 s.21 
After completion of  the study, hospital and family physician charts were reviewed to 
double-check the reliability of  the data, and to identify any prescriptions of  oral pred-
nisolone during the study period.
Analysis 
Adherence was calculated as the number of  Smartinhaler®-recorded inhaled doses ex-
pressed as a percentage of  the number of  doses prescribed, either between midnight 
and midday or between midday and midnight for morning and evening doses, respec-
tively, or at any time during the day for once-daily dosing. Adherence was censored 
at 100% of  the prescribed dose. We assessed the association of  adherence during the 
two months preceding each follow-up visit to each indicator of  asthma control at the 
follow-up visit, using nonparametric methods because of  the highly skewed distributi-
on of  adherence. 
Because a number of  children used a lower ICS dose, or no ICS at all, during summer-
time, and because we expected asthma control to deteriorate during winter months 
because of  viral infections, we performed separated analyses for summer (May to 
September) and winter (October to April) seasons, expecting the relationship of  adhe-
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rence to asthma control to be stronger in winter. To compare the effects of  moderate 
and good long-term adherence on asthma control, we also assessed the association of  
asthma control to the 12-month adherence dichotomized as good (>80%) and mode-
rate (50-80%) adherence.
Based on all the collected information about asthma control, the child’s long-term 
asthma control was classified as ‘well-controlled asthma’ (no or infrequent mild 
symptoms during the study period), ‘mostly well-controlled asthma’ (well controlled 
asthma, except for 1 or 2 episodes with moderate to severe symptoms sometimes 
requiring a course of  prednisolone), ‘mild uncontrolled asthma’ (recurrent periods 
with mild to moderate asthma symptoms), and ‘uncontrolled asthma’ (recurrent peri-
ods with moderate or severe asthma symptoms including one or more exacerbations 
needing prednisolone).   
Correlations between asthma control and clinical and demographic variables were 
assessed using Spearman’s rank correlation coefficient. Because this yielded no statisti-
cally significant correlations, we refrained from multivariable analyses between adhe-
rence and asthma control, adjusting for other clinical and demographic variables.   
Ethical considerations
This study was approved by the hospital ethics review board and all parents provided 
written informed consent.
RESULTS
Of  the 138 eligible patients, 104 children (75%) entered the study after informed con-
sent was obtained, and 81 children (78% of  those enrolled) with persistent prescrip-
tion of  ICS completed the 12-months follow-up (figure 1). The clinical and demo-
graphic characteristics of  these patients are presented in table 1. Most participating 
children had well-controlled asthma using only low dose ICS maintenance therapy. 
Reliable and reproducible lung function results were recorded in 60 patients (74%), 
and inhalant allergen sensitisation results were available in 77 (95%, table 1).
The frequency distribution of  adherence to daily ICS is presented in figure 2. Medi-
an (interquartile range, IQR) adherence was 87% (70% to 94%). 51 children (63%) 
had high adherence (>80% of  prescribed dosages); adherence rates below 50% were 





13 children not eligible
- severe comorbidity (n=2, severe 
  neurologic disorders)
- problems understanding Dutch 
  language (n=4)
- remission of asthma (n=3),
- using devices not compatible with 
  Smartinhaler® (n=4)
125 children asked for 
participation
Parents of 21 children declined 
participation
104 patients enrolled
81 children completed 
follow-up
23 children lost to follow up:
- physican stopped maintenance 
  medication (n=16)
- movement to other area (n=2)
  withdrawn by parents (n=5)
Figure 1. inclusion of patients
Figure 2. Electronically measured adherence to inhaled corticosteroids (n=81)
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Table 1. Characteristics of study patients at baseline (n=81)
Demographic and clinical characteristics
Age (mean; range; yrs) 4.6 (2.2 to 6.9)
Male gender (%) 51 (63%)
Parental diagnosis of asthma 33 (41%)
Household smoking (%) 24 (30%)
Maternal educational level (1 = low and 7 = high) 5 (4 to 7)
Positive specific IgE to inhalant allergens (n=77) 43 (56%) 
Hospitalisation ever for asthma exacerbation (n, %) 40 (49%)
Duration of outpatient clinic asthma care before study (months) 17 (8 to 26)
FEV1 (z-score, n=33) 0.67 ± 1.1
FVC (z-score, n=33) 0.26 ± 1.4
Rint (z-score, n=27) 1.70 ± 3.1
ACQ 0.5 (0.2 to 1.3)
PACQOL 6.2 (5.3 to 6.8)
Baseline medication
Inhaled corticosteroids (ICS) 73 (90%)
ICS and long-acting bronchodilators (%) 8 (10%)
ICS dose (fluticasone®; mean; range; μg) 250 (125 to 500)
nasal corticosteroids 19 (23%)
oral antihistamine 20 (25%)
Data are presented as mean ± SD, or as median (interquartile range) unless otherwise stated; 
ACQ: Asthma Control Questionnaire (<0.75 = well-controlled asthma, >1.5 = not well-controlled 
asthma); PACQOL: paediatric asthma caregiver quality of life questionnaire (1 is low and 7 is 
high quality of life),17, 18 ; Ig: immunoglobin; FEV1: forced expiratory volume in one second; FVC: 
forced vital capacity; Rint: respiratory resistance by the interrupter technique
Overall, asthma control during the 12-month study period was high and lung function 
was normal (table 2). Only 2 children were hospitalized because of  an asthma exacer-
bation during the study period. The fifteen children (19%) that received a prednisolo-
ne course during the study period had similar long-term adherence (median 87%, IQR 
54% to 92%) compared to children not receiving prednisolone (median 87%, IQR 
72% to 94%, p=0.463). Exacerbations requiring prednisolone courses were not asso-
ciated with low adherence in the two months preceding the exacerbation (p=0.552). In 
two children, however, exposure to lower ICS dose was associated with exacerbation 
occurrence: the exacerbation requiring prednisolone followed a physician-prescribed 
decrease of  ICS dose in one child, and a pharmacy error (delivery of  MDIs with lower 
ICS dose than prescribed) in the other. 
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Table 2.  Indicators of asthma control and their association with electronically measured 
adherence during the 2 months before asthma control was assessed, and with 








children with good 





ACQ winter (n=172/154/149) 0.58 (0.00 to 1.17) -0.16 0.048 0.003
ACQ summer (n=118/106/97) 0.50 (0.00 to 1.00) -0.31 0.001 0.001
PACQOL winter (n=95/79/83) 6.6 (5.8 to 6.8) 0.22 0.053 0.081
PACQOL summer (n=54/51/46) 6.6 (5.9 to 6.9) 0.30 0.034 0.024
VAS asthma control physician 
winter (n=85/76/88)
89 (82 to 95) 0.22 0.063 0.002
VAS asthma control physician 
summer (n=79/71/59)
88 (82 to 94) 0.24 0.044 0.003
FVC at 6 months 
(z-score, n=39/38/33)
-0.3 (-1.2 to 0.7) 0.36 0.028 0.032
FEV1 at 6 months 
(z-score, n=39/38/33)
0.0 (-0.6 to 0.9) 0.29 0.079 0.040
FVC at 12 months 
(z-score, n=42/41/36)
0.3 (-0.8 to 1.3) 0.30 0.060 0.047
FEV1 at 12 months 
(z-score, n=42/41/36)
0.7 (-0.5 to 1.1) 0.29 0.065 0.008
FeNO at 6 months (n=17/17/12) 15 (9 to 21) -0.36 0.162 0.808
FeNO at 12 months 
(n=19/19/17) 12 (8 to 19) -0.56 0.013 0.037
Data are presented as mean ± SD, or as median (interquartile range) unless otherwise stated; 
ACQ: Asthma Control Questionnaire(<0.75 = well-controlled asthma, >1.5 = not well-controlled 
asthma); PACQOL: paediatric asthma caregiver quality of life questionnaire (score 1 to 7, 1 is 
low and 7 is high quality of life)17, 18 ; FEV1: forced expiratory volume in one second; FVC: forced 
vital capacity; Rint: respiratory resistance by the interrupter technique.
The relationship of  adherence to asthma control, lung function, and FeNO values is 
presented in table 2. Adherence was associated with several indicators of  asthma con-
trol, and asthma control was significantly better in children with good than in those 
with moderate adherence (table 2). 
Against our expectations, the association between adherence and parent-assessed 
asthma control was stronger in summer than in wintertime (table 2). When filling out 
90
Chapter 6
the ACQ, many parents made remarks about having difficulties to attribute symptoms 
(cough) to viral respiratory tract infections or to asthma; this may have interfered with 
the association between adherence and asthma control. Children with high adherence 
had better spirometry results and lower FeNO levels, but no association was found 
between adherence and Rint results (table 2). 
In table 3, adherence levels in different categories of  asthma control are being compa-
red. Four patients had severe uncontrolled asthma, 3 of  which had very high adhe-
rence to ICS/long acting bronchodilator combination therapy, along with a prescrip-
tion of  nasal steroids and antihistamines for comorbid allergic rhinitis. Compared to 
patients with (mostly) well-controlled asthma, children with mild uncontrolled asthma 
had significantly lower adherence rates (95% CI of  difference in median adherence 
rates 3% to 28%, p=0.008), and mild uncontrolled asthma was rare among children 
with good adherence levels (figure 3). Good adherence was accompanied by well-con-
trolled asthma in 67% of  the children, but not associated with a lower likelihood 
of  mild uncontrolled asthma or uncontrolled asthma (figure 3a). To adjust the re-
lationship between adherence and asthma control for the potential confounding by 
overtreatment of  mild episodic asthma symptoms or asthma in clinical remission, we 
repeated this analysis taking only those patients into account who were still using ICS 
two years after completion of  the 12-months follow-up of  adherence. The results are 
presented in figure 3b. There was a clear trend of  higher levels of  asthma control with 
higher levels of  adherence (p=0.032), and patients with moderate levels of  adherence 
(50-80%) were significantly more likely to have mild uncontrolled asthma (p=0.028). 
Of  all other clinical and demographic characteristics, only inhaled allergen sensitiza-
tion showed a trend to an association with good asthma control although it did not 
reach statistical significance (p=0.075), and sensitization prevalence was comparable in 
adherent (>80%) and non-adherent (<80%) patients. Therefore no other confounders 
of  the relationship of  adherence and asthma control were identified.   
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Table 3. Level of long-term asthma control in the study population*





Well-controlled asthma: no symptoms or infre-
quent mild symptoms during study period
49 (60%) 88% (72 to 94%)
Mostly well-controlled asthma: Most of the time 
well-controlled asthma, but up to three episodes 
with symptoms
15 (19%) 88% (57 to 92%) p=0.302
Mild uncontrolled asthma: persistent mild to 
moderate severe symptoms, most children none 
exacerbation
13 (16%) 74% (53 to 84%) p=0.008
Uncontrolled asthma: persistent moderate to 
severe symptoms including exacerbations
4 (5%) 95% (70 to 98%) p=0.288
*: asthma control based on parental reports, physician’s assessment and chart review; IQR: 
interquartile range
Figure 3. Relationship between asthma control and adherence in all patients (figure 3a) and 
in those patients in whom ICS were continued for at least two years after completing the 




This study demonstrates the key role of  adherence to ICS in achieving and maintai-
ning asthma control in young children. In the large majority (79%) of  these patients, 
asthma could be well-controlled most of  the time over 12 months of  guideline-ba-
sed comprehensive asthma care. Only 4 children (5%) had uncontrolled asthma, one 
of  which had poor adherence to ICS. In comparison to earlier studies of  long-term 
adherence in childhood asthma,6, 22 median adherence was remarkably high (87%) in 
our study cohort. Despite the overall high levels and associated limited variability of  
both adherence and asthma control, a significant and consistent association was found 
between the two variables. Asthma control was significantly better in children with 
good (>80%) than in those with moderate adherence (50-80%) (table 2, figure 3), and 
this association was independent of  clinical and demographic characteristics. In parti-
cular children with persistent mild asthma symptoms had lower adherence rates (table 
3). Exacerbations requiring oral prednisolone and mild intermittent asthma symptoms 
were not associated with poor adherence in this cohort with overall high adherence 
and good asthma control.  
Previous studies have also shown a high prevalence of  well-controlled asthma during 
comprehensive guideline-based asthma care.11,12,23 Because such comprehensive care 
comprises several components that may promote asthma control, including reduction 
of  allergen and irritant exposure, identification and treatment of  relevant comorbidi-
ty, and ensuring proper inhalation technique and self-management, the independent 
role of  adherence in determining asthma control remained uncertain in these studies. 
Our finding of  a significant association of  electronically measured adherence to both 
short-term and long-term asthma control, including lung function, in this population 
of  young asthmatic children, independent of  treatment of  comorbidity  and other 
clinical characteristics, shows that adherence to ICS plays a key role in achieving and 
maintaining asthma control. In previous studies, substantially different levels of  ad-
herence needed to achieve asthma control have been reported, ranging from 40-60% 
to higher than 80%.6,22 In these studies, however, a high prevalence of  children with 
short-term asthma control despite low adherence to ICS was observed, suggesting 
ICS overtreatment of  mild intermittent symptoms or asthma in clinical remission. To 
adjust for this potential confounder, we reanalysed the relationship between adherence 
and asthma control in a subgroup of  children from our study who were still using ICS 
for persistent asthma two years after completion of  the present study (figure 3b). Be-
cause the association between adherence and asthma control was stronger in patients 
with on-going persistent asthma (figure 3b) than in the whole population comprising 
both on-going persistent asthma and asthma in clinical remission (figure 3a), clini-
cal remission of  asthma in young children may help to explain why asthma can be 
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well-controlled in this age group despite poor adherence. Our results show that the 
relationship between good adherence and good asthma control is particularly strong 
in children who need ICS maintenance treatment for prolonged periods of  time, thus 
emphasizing the pivotal role of  optimal adherence to achieve asthma control in child-
ren with chronic persistent asthma. 
International guidelines recommend stepping up maintenance therapy in case of  
insufficient asthma control in the preceding months.10 Our results suggest that adhe-
rence should be considered as a potential cause of  such reduced asthma control, in 
particular when parents report that their child has frequent mild asthmatic symptoms 
(table 3). In clinical practice, many physicians will not step up maintenance therapy 
after a short episode of  uncontrolled asthma while children have well-controlled asth-
ma most of  the time, and our results suggest that this pattern is not a marker of  poor 
adherence to ICS. 
Strengths and limitations
The main strengths of  our study include the longitudinal comprehensive assessment 
of  asthma control and the objective, validated assessment of  adherence over 12 
months of  follow-up. Asthma control is a multidimensional clinical construct which is 
not easily captured by a single questionnaire, particularly in children.24 The assessment 
of  asthma control by different methods in our study, using parental and physician 
assessment, validated questionnaires, and lung function, is most likely to capture the 
clinical concept of  asthma control described in asthma guidelines. Previous studies 
on the relationship between asthma control and adherence are hampered by a limited 
assessment of  asthma control, use of  less reliable methods of  measuring adherence, 
or short follow-up. Our long-term follow-up allowed us to analyse the influence of  
seasonal changes in adherence and asthma control, along with a range of  potential 
clinical and demographic confounders, which enhances the robustness of  the relati-
onship between adherence and asthma control that we found. 
The most important limitation of  our study lies in its generalizability. Most parents 
and children in our study population came from Caucasian middle-class families, and 
the study was performed in a dedicated, secondary care, specialized asthma clinic. 
However, previous studies pointed out the importance of  ICS adherence in deter-
mining good asthma control in inner-city populations from ethnic minorities.11,12 In 
addition, the relationship between adherence and asthma control in our study  was not 
influenced by demographic and clinical characteristics of  the study population. This 
suggests that adherence is a key factor in determining asthma control, irrespective of  
study setting and ethnic or social background of  the population studied. Finally, the 
limited variability of  asthma control and adherence in this study population may limit 




In most young children with asthma, well-controlled asthma can be achieved by 
comprehensive guideline-based asthma care. The role of  adherence to ICS in this 
relationship was crucial, because even in this highly adherent, well-controlled popula-
tion, adherence was the only determinant significantly associated with asthma control, 
irrespective of  other clinical or demographic characteristics. Persistent mild symp-
toms were a marker of  suboptimal adherence. Adherence to ICS is a crucial factor to 
achieve and maintain asthma control in young children and should be a key focus of  
asthma care in this age group. 
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Every parent tells a story: 
Why non-adherence 












Effective self-management and adherence to inhaled corti-
costeroids are points of  particular interest in comprehensi-
ve asthma care. In spite of  this care, however, a number of  
parents and children remain non- adherent. The reasons for 
this non-adherence have up till now been unknown, because 
previous adherence studies have based their findings either on 
populations with poor adherence or on unreliable self-reported 
adherence.  This study was designed to explore factors that 
contribute to persistent non-adherence to inhaled corticos-
teroids in children ranging between two and twelve years of  age 
receiving comprehensive asthma care.
Methods
This qualitative study was based on in-depth interviews which 
took place in the homes of  parents whose children had com-
pleted a one-year follow-up of  electronically measured adheren-
ce to inhaled corticosteroids. Rich and comprehensive descrip-
tions of  parents’ own accounts of  self-management behavior 
were obtained by using active listening techniques. Each inter-
view was recorded and transcribed verbatim followed by data 
analysis using standard methodology for qualitative studies.
Results
Twenty children’s parents (mean age 5.9 years) were intervie-
wed. Distinctive patterns of  modifiable barriers to adherence 
emerged, including a novel finding of  parents misjudging of  
their children’s capacities to manage the daily use of  medication 
by themselves. Persistence of  non-adherence appeared to be 
caused by a number of  maintaining factors. Most noticeable 
factors were unawareness of  non-adherence with both parents 
and health care providers, a lack of  drive in parents to achieve 
high adherence and ineffective parental problem-solving beha-
vior. 
Conclusions 
This study has identified known and novel barriers to adheren-
ce. Overcoming these barriers should start with objectifying 
non-adherence. Interventions should focus on parental motiva-




Over the last decade, several studies have explored determinants of  adherence to 
inhaled corticosteroids (ICS) in children with asthma.1 In most studies, children only 
received between 30 to 70 percent of  the prescribed doses. Adherence appeared to 
be particularly poor in ethnic minorities from lower socioeconomic status.1-4 These 
fixed demographic determinants of  poor adherence, however, are largely mediated 
by modifiable risk factors for low adherence, such as parental illness perceptions and 
medication beliefs.1-3,5 If  these modifiable risk factors are addressed in guideline-based 
comprehensive asthma care,6 high adherence and good asthma control can be achie-
ved even in this group of  underprivileged children with asthma.7
 We have recently shown a comparable pattern of  high median adherence in pre-
school children from middle class families receiving  regular, comprehensive, mul-
tidisciplinary asthma care.8 This was associated with most parents expressing illness 
perceptions and medication beliefs in accordance with the medical model of  asthma.9 
However, even in populations with such high median adherence, variability in adhe-
rence remains. In our study in pre-school children whose median adherence was 92% 
over a three-month period, a third of  the children received less than 75% of  the pres-
cribed doses of  ICS.8 Reasons for such “persistent non-adherence” in spite of  com-
prehensive guideline-based asthma care are unknown. Previous adherence studies have 
focused on populations with poor adherence, or have relied on parental or patients’ 
self-reported adherence which highly overestimates objectively measured adherence.10
This study was designed to explore determinants of  persistent non-adherence to 
inhaled corticosteroids in parents and children receiving comprehensive guideline-ba-
sed asthma care. We used electronically measured adherence, which ensures capturing 
unreported and unwitting non-adherence. We intended to explore every potential re-
ason for non-adherence and did not want to limit ourselves to identifying established 
barriers to adherence. We therefore chose a qualitative study design, allowing for a rich 





We have recently completed a one-year observational follow-up study of  electronically 
measured adherence to ICS maintenance therapy. We followed a group of  2-12-year-
old children  with asthma in our secondary care pediatric asthma outpatient clinic.8,9 
To ensure optimal asthma management and adherence, our asthma care comprises 
repeated teaching of  tailored asthma self-management, including: 6, 12  
• Discussing parents’ perceptions about asthma and its treatment.
• Establishing and maintaining a partnership between health care providers and the 
patient/parent dyed. 
• Ensuring concordance on treatment and its goals with parents and those children 
old enough to participate in the discussion.
• Stressing the importance of  adherence to daily ICS treatment. 
To achieve this, patients and their parents visited the clinic four to six times during 
their first year of  follow-up, and two to four times per year afterwards. 
Our study aimed to explore determinants of  non-adherence persisting in spite of  
such comprehensive care. In order to achieve this, we interviewed parents about their 
medicine-giving behavior as electronically measured during the follow-up study. Even 
though we focused on non-adherence, we included children’s parents from the whole 
adherence spectrum. The interviews with adherent parents served the purpose of  en-
riching our analysis by allowing us to contrast the ways medicines were used between 
parents with low and high adherence.
Selection of  eligible patients and parents
For this qualitative study, all 2-12-year-old children who had completed a one-year 
follow-up of  electronically measured adherence to ICS (details of  which were publis-
hed previously)8 were eligible for inclusion. The consecutive eligible children’s parents 
were asked to allow deblinding of  the results of  long-term adherence measurements 
and to participate in an in-depth interview on their (non-)adherence behavior. Based 
on the results of  electronically measured adherence over the completed one-year fol-
low-up period, parents who had given informed consent were divided into two groups 
of  at least ten parent couples. These groups represented those with adherence below 
75 percent and those with adherence above 75 percent.13 In both groups, random 
number tables were used to rank the children, stratified for age (younger than six and 
6-12-year-olds). From the top of  each of  these ranked lists, parents were included for 
interviews until saturation for each group had been reached (i.e. additional interviews 
were not expected to yield new information on patterns of  non-adherence). 
101
Chapter 7
Parental educational level was assessed by recording the highest level of  education 
completed, and was classified on a 7-point scale, ranging from 1 (high school drop-
outs; only completed primary education) to 7 (completed college or university educa-
tion).
Interviews 
Two researchers (TK and SL) visited parents at their homes for a semi-structured in-
depth interview lasting approximately one hour. We started each interview by asking 
the parents to estimate the one-year ICS adherence achieved in their child, after which 
we revealed the results of  one-year electronically measured adherence. The similarity 
or difference between the parent-estimated and actually measured adherence was 
used as a starting point to explore parental (non-)adherence behavior without passing 
judgment. Active listening techniques were used to obtain a rich and comprehensive 
description of  the parents’ explanation for following or deviating from the health 
care team’s recommendations of  ICS dose and dosing frequency. As the character 
of  the interviews was home-based, children aged eight to twelve commonly engaged 
in the interview themselves. When the interviewers felt they had obtained a compre-
hensive and accurate overview of  parental and children’s (non-)adherence behavior, 
they summarized it, inviting modification by parents until they accepted it as accurate 
and complete. Following the principle of  grounded theory methodology, findings of  
previous interviews were used to guide subsequent interviews in exploring patterns of  
adherence behavior.11 Explanations for non-adherent behavior were also specifically 
discussed with parents with high adherence. This served the purpose of  finding out 
if  such explanations were less prevalent in adherent families. It also improved under-
standing of  the reasons why parents confronted with the same problem (e.g. a child 
unwilling to take medication) showed different behaviors.  
Analysis
Each interview was recorded and transcribed verbatim and analyzed using standard 
methodology for qualitative studies.8,9 The transcripts of  the first two interviews were 
coded independently by two researchers (TK, SL) using qualitative analysis software 
(Kwalitan®, Kwalitan advice, Malden, the Netherlands) with good agreement (Cohen’s 
kappa values 0.80 and 0.90, respectively). Subsequent transcripts were coded by one 
researcher (SL) and cross-checked by another (TK). Differences in coding were re-
solved by consensus. Three distinct patterns of  non-adherence behavior and concep-
tual ideas underlying the persistence of  each of  these non-adherence behaviors were 





This study was approved by the hospital ethics review board; all parents provided writ-
ten informed consent.
RESULTS
42 out of  69 children’s parents (61 percent) who had been asked to participate in our 
study gave informed consent to deblind study results for the interview (figure 1). Re-
fusal of  deblinding consent was equal in adherent and non-adherent parents. Satura-
tion was reached after ten children’s parents with poor adherence (below 75 percent) 
and ten with high adherence (above 75 percent) had been interviewed. The mean age 
of  the children whose parents were interviewed was 5.9 years. Median education level 
of  parents was 5 (range 3-7).
Individual stories, recognizable patterns
The interviews were all set around a kitchen or dinner table, allowing for a low-profile 
atmosphere. Parents were all happy to discuss the way they managed giving medicine 
in detail. Each single interview provided us with a unique story about how parents 
and children cope with the child’s asthma and the recommendation of  daily ICS use. 
135 eligible patients
- 22 children’s parents declined  
  participation
- five children’s parents not 
  reached by telephone
69 children’s parents approached
42 children’s adherence rates 
deblinded 
Figure 1. inclusion of patients
20 children’s parents interviewed
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With the exception of  one family, all interviews could be summarized with a clear 
and mutually agreed description of  how medication was taken. All of  the parents 
reported that they had been recommended to provide daily ICS to their child. Even 
though some parents reduced the dose, all expressed the intention to use ICS regularly 
in order to achieve good asthma control in their child.  We were able to identify three 
patterns of  non-adherence behavior (table 1). Within these patterns, a number of  bar-
riers as well as factors contributing to the persistence of  these barriers were identified 
(table 1).
1. Intentional non-adherence
One group of  parents deliberately deviated from the pediatrician’s advice. They adjus-
ted the ICS dose according to what they thought was the desired or obtained level of  
asthma control in their child. Based on their own experience, these parents increased 
the dose during a ‘bad’ season, or when their child showed increased symptoms. These 
parents were all convinced they were self-managing their child’s asthma well. 
Most commonly, children were given a single daily dose instead of  the recommended 
two. In these children, electronically measured adherence could thus be as low as 50 
percent, with parents readily confirming the accuracy of  this number. They did not 
discuss their dose-reducing behavior with the pediatrician, unless the pediatrician 
explicitly asked them about their ICS use. Parents’ main reasons for lowering the ICS 
dose were concerns about ICS side effects or resistance against medication in general. 
These parents were convinced their child needed ICS treatment, but their aim was to 
optimally balance the pros and cons of  ICS. 
Parents with good adherence differed from these non-adherent parents in two ways. 
Some of  these highly adherent parents expressed few if  any concerns about (side 
effects of) ICS and therefore did not deliberately balance pros and cons of  ICS. Other 
highly adherent parents did express a high level of  concerns about ICS use, but were 
convinced that their child needed the ICS two times a day nevertheless.
2. Family related barriers
Parents in this group tended to give a higher estimation of  the level of  adherence than 
the electronically measured adherence would show. Unaware of  their non-adherence, 
these parents would not discuss this with their pediatrician. Different families were 
confronted with different sets of  barriers that kept them from regular ICS use. Barri-
ers such as relational or economic issues or parental psychiatric illnesses seemed fixed 
of  difficult to modify at first sight. After exploring parental and children’s adherence 
behavior in more detail, however, in most families barriers appeared modifiable. Child 
raising issues, for example, were often found to be important barriers, as in cases 
where parents would skip a dose when children refused the use of  their inhaler simply 
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Table 1. Patterns of barriers to adherence and factors contributing to the persistence of these 
barriers.
Patterns of barriers Quotes from the interviews
Intentional non-adherence:
• concerns about medication 
• resistance against meds in   
    general
“I was rather skeptical about the meds, but I also saw 
my daughter’s breathlessness. Well, then you weigh your 
options in your mind”
“No, I don’t follow each of the pediatrician’s recommen-
dations. I look at my child, whether he needs the meds or 
not.”
Unplanned non-adherence 
associated with family-related 
barriers:
• Child raising issues
• Missing family routines
“Do I have to upset him completely, only for such an 
inhalation? How hard should you push? That’s a difficult 
decision sometimes.”
“I have this experience with my daughter (also an asthma-
tic), of controlling her like a cop. That’s something I don’t 
want to go through again.“
“I should stick to the rules that we decided on, but that’s 
not what happens”
Unplanned non-adherence asso-
ciated with self-management of 
children.
• Parental misperceptions
    about children’s capacity of 
    self-management
• Children incapable of self-ma-
   naging daily use of medication
“When he received the powder inhaler, when he was 
eight, we thought he could take the meds on his own.”
 “He’s already 9 years; he has to figure out for himself what 
he wants, and how to get things done.”
“The meds are just annoying. I see the inhaler when I go to 
bed, but I don’t take it”
Maintaining  factors
Parent related:
• unawareness of non-adherence “That he takes his meds only half of the time, that’s quite 
shocking to me.”
• not reporting of non-adherence “Giving the meds every day once a day, that’s so obvious 
to me, and the right thing to do. I think that’s the reason I 
don’t report this to the pediatrician.”
• lack of motivation to achieve 
    high adherence
“Well, I do notice he doesn’t take his meds. I see the 
counter of the inhaler still on the same number, just like 
some days before. Then you think: okay….. but, you know, 
I have to deal with a lot of problems…” 
• ineffective problem-solving 
    behavior
 “In the evening, he usually falls asleep on the couch. Then 
I don’t wake him up for his meds.”
Physician related:
• unawareness of non-adhrence
• not (specifically) asking about
    the use of ICS
• unawareness about young
   children self-managing their 
    medication
“He (the pediatrician) never informed about the details of 
using the medication: about who is responsible, and how 
we are doing it”
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to avoid upsetting their child. Augmented by the absence of  daily medicine taking rou-
tines, families were prone to simply forget giving the medication altogether. Parents 
were aware of  these barriers, but accepted them to avoid family stress. 
Compared to the self-management of  parents with good adherence, two differences 
emerged. First, parents with good adherence were dedicated to use ICS regularly, 
whereas parents with poor adherence regarded the achieved adherence rates as the 
best they could possibly do. Highly adherent parents put giving medication before 
avoiding to upset their child. Secondly, parents with good adherence showed good 
problem-solving skills by having developed medicine taking routines to avoid forget-
ting the medication.
 
3. Transferring excessive responsibility to children
In this group, children were given full responsibility for taking their own medicine. 
Children from eight to ten years of  age used their inhaler without parental supervisi-
on. A number of  these children’s parents were astonished to find out that the adhe-
rence rates that had been recorded  for a year turned out to be much lower than they 
had expected. These parents had been convinced that  eight to ten year-old children 
could take such a responsibility. In families struggling with relational or economic 
problems, children were given the responsibility for taking their own medicine at an 
even younger age, in order to reduce the number of  issues that needed tackling.  Even 
though aware of  their child’s non-adherent behavior, some parents decided to ignore 
it in their wish to avoid a fight about taking medicine. Their decisions to do so were 
either based on the assumption that too much pressure on the child would lead to 
more resistance, or on the belief  that giving the child full responsibility would foster 
their independence. Lacking the drive to achieve good adherence as well as ineffective 
ways of  solving problems, however, lie at the bottom. Parents that were aware of  their 
child’s non-adherence relied on the pediatrician to try and change their child’s behavi-
or.   
In children with high adherence, parents were much more involved in supervising 
their children’s ways of  taking medication. These parents were more dedicated to 
achieve good adherence and expressed the view that children could not be expected to 
self-manage their own medication before the age of  12.
DISCUSSION
Through in-depth interviews, which took place in the domestic environment of  
children with asthma that remained non-adherent in spite of  receiving guideline-based 
comprehensive asthma care, we gained  insight into three groups of  barriers that kept 
these patients from being adherent and into determinants that explained why these 
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barriers could not be overcome. Some parents faced non-adherence even though they 
were conscientiously dealing with medication. They were adequately self-managing 
medication by giving the lowest possible ICS dose. Other parents, however, poor-
ly planned medication. They were either overwhelmed by complex family, social or 
child-raising issues, or gave responsibility for medication to the children themselves 
without supervising them. Further probing suggested that in those parents a lack of  
drive or ineffective problem-solving skills lay at the bottom of  why barriers would not 
be overcome.  These factors, together with parental as well as health care provider’s 
unawareness of  the degree of  non-adherence were identified as the underlying causes 
of  persistent non-adherence. 
Parents who deliberately balanced the pros and cons of  prescribed medication use, 
based on their own illness perceptions and medication beliefs, formed the group of  
‘intentional non-adherers’. Previous studies have described this as a cause of  proble-
matic non-adherence: not taking medication at all or only if  symptomatic.14-16 This is 
the first study to demonstrate that intentional non-adherers may also show adequate 
self-management, aiming to achieve good asthma control with the lowest possible 
dose of  daily ICS. The parents in this group in our study expressed constructive illness 
perceptions and medication beliefs, concordant with the medical model of  asthma, 
after receiving comprehensive self-management education.9 To avoid misclassifying 
such parents as being problematically non-adherent, physicians and parents need to 
reach concordance on the ICS dose and on modifying this dose based on the level of  
asthma control achieved.17 Finally, physicians should actively check the current dose 
being given at each follow-up visit.
This study confirmed previous findings that unplanned non-adherence is common, 
in particular in families with relational or economic issues.2,18 As reported by previous 
studies, this relationship is mediated by potentially modifiable barriers, including a lack 
of  medication taking routines and ineffective child raising strategies.2, 14,18-20 Given that 
parents and physicians are usually unaware of  the degree of  unplanned non-adheren-
ce, current guideline-based comprehensive asthma care is not sufficient.10,19,21 Factors 
contributing to the persistence of  these potentially modifiable barriers emerged in 
our study. These included the lack of  motivation to achieve good adherence and the 
presence of  ineffective problem-solving behavior. The latter has been noted in a 
survey of  diabetes educators. They reported that appropriate problem-solving was 
the most difficult skill to teach patients.22,23 A large trial in asthmatic adults showed 
no benefits of  problem-solving education, and the authors suggested that patients’ 
lack of  motivation to achieve high adherence was the main reason for this failure.24 
Similarly, an asthma outreach program in inner-city children with asthma in the USA 
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was of  limited benefit when parents lacked the motivation to participate.25 Apparently 
these maintaining factors represent determinants of  self-management that are difficult 
to modify, supporting our analysis about the role of  such underlying factors in the 
persistence of  modifiable barriers.
Perhaps the most striking novel finding of  our study was the excessive responsibility 
given by parents to children at a relatively young age to self-manage the daily use of  
their own medication, without parental supervision. This represented a major cause 
of  non-adherence. An increase in shared responsibility for asthma self-management 
has been reported from the age of  8 years,26,27  particularly for daily preventer medi-
cation use.28,29 Until now, the effect of  this practice on adherence has been unknown. 
The only previous study investigating this effect (reporting no effect) used paren-
tal-reported adherence.26 Results were highly unreliable for two reasons. Both parents 
and children are generally hesitant to disclose poor adherence and parents can also 
be unaware of  their child’s poor adherence. In contrast to common belief,14 children 
below the age of  10 to 12 years seem to be unable to take responsibility for their own 
taking of  medicine.30,31 To identify and overcome this barrier to adherence, parental 
belief  about the self-management responsibility of  their child should be discussed 
during follow-up visits, along with the associated lack of  motivation to achieve good 
adherence and ineffective problem-solving behavior. Parents should likewise receive 
counseling in supervising their child’s taking of  medicine at least until their child rea-
ches the age of  12.
Clinical implications
This study has shown the importance of  assessing non-adherence objectively. Many 
parents and physicians appear to be unaware of  the extent of  non-adherence. Non-ad-
herence needs to be identified before barriers underlying it can be discussed and mo-
dified. It has been shown that feeding back results of  objectively measured adherence 
improves adherence, but only for a short period.32,33 This may reflect a lack of  parental 
motivation or ability to control asthma, in particular in families with competing prio-
rities and problems. Whether motivation enhancing techniques such as motivational 
interviewing may change long-term adherence in such patients remains to be establis-
hed. Short-term benefits of  this approach have been established in inner-city asth-
matic adolescents.34 In families struggling with many and complex daily life issues, a 
child’s asthma may be a minor problem not getting priority. An open discussion about 
the complex issues of  coping with daily life and about the child’s ability to self-manage 
the daily use of  their medication may help to achieve concordance with parents on the 
degree of  achievable asthma management and control in these patients, At all costs, 




The main strength of  this study lies in the qualitative design, which allowed for an 
in-depth exploration of  barriers to adherence during guideline-based comprehensive 
asthma care. A home-based environment for the interviews appeared to be the ideal 
environment to explore and discuss parental explanations for following or deviating 
from the pediatrician’s recommendation to give daily ICS to their child. The use of  
electronic devices ensured detection of  unwitting non-adherence. The limitation of  
this study is that it is still impossible to make generalizations. Whether our findings, in 
particular our finding of  excessive medication responsibility given to children, are ap-
plicable to populations of  children with asthma in primary care and different settings 
remains to be established.
CONCLUSIONS
This study shows that persistence of  non-adherence in spite of  comprehensive ast-
hma care can be related to both adequate and inadequate asthma self-management. 
Adequate self-management that nevertheless leads to non-adherence is related to pa-
rents’ intentions to achieve optimal asthma control with the lowest possible ICS dose. 
Inadequate self-management is caused by potentially modifiable barriers, of  which 
child-raising issues and lack of  family routines are barriers that have been identified 
before. In this study, a novel barrier to adherence was identified: full responsibility 
given to children at a young age to self-manage their daily use of  ICS. The persistence 
of  barriers was related to limitations in parental problem-solving behavior and a lack 
of  motivation to achieve high adherence as well as unawareness of  non-adherence 
with both parents and health care providers. Barriers to non-adherence may be over-
come by first objectifying non-adherence behavior, after which an open discussion 
with parents and children about their self-management behavior should take place, 
preferably in their own homes. Effectiveness of  interventions to improve adheren-
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“The study described in this thesis was designed to identify determinants of  long-
term adherence to daily maintenance medication in children with asthma. Before 
this study was undertaken, there was a paucity on studies of  long-term adherence 
in children with asthma, which is striking because asthma is a chronic disease which 
usually requires maintenance treatment taken for many years. Previous studies on 
adherence in children with asthma were also hampered by the lack of  objective 
and reliable assessment of  adherence. Most studies used self-report or pharmacy 
refill rates, both of  which have been shown to be unreliable. Very few studies using 
electronic data loggers have been performed in children with asthma, and most of  
these studies used only short-term follow-up. 
When the study was designed, parental illness perceptions and medication beliefs 
were hypothesized to be the main determinant of  long-term adherence in child-
ren with asthma. Therefore, these illness perceptions and medication beliefs were 
assessed comprehensively when patients were enrolled into the study, with a range 
of  validated questionnaires designed for this purpose. Numerous other putative 
determinants of  adherence were also assessed, along with a careful characterization 
of  asthma control during follow-up. The study employed a mixed methods design, 
with both quantitative methods (measuring adherence electronically throughout 
1-yr follow-up, and analysing the effects of  various determinants on adherence 
measured in this way) and qualitative research methodology (focus group and 
individual interviews aimed at acquiring a rich and detailed description of  parental 
views on the necessity of  maintenance medication, their concerns about this treat-
ment, and their strategies and behaviour regarding daily maintenance medication).
MAIN RESULTS OF THE STUDY
This study showed: 
1. a very high median adherence during 3-months follow-up of  92% in children with 
asthma 2-6 years of  age (chapter 3) and a similarly high median adherence during 
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12-months follow-up of  84% in asthmatic children 2-12 years of  age followed up 
in secondary care (chapter 5). Considerably poorer adherence was measured in a 
group of  asthmatic children in primary care (median 66%, chapter 5). 
2. striking differences in the illness perceptions and medication beliefs between pa-
rents from primary and secondary care as revealed by the focus group interviews 
(chapter 2) and confirmed by the quantitative assessment of  these perceptions 
and beliefs (chapter 5). Compared to parents from primary care, parents from 
secondary care had illness perceptions more concordant to the medical model of  
asthma and higher perceived necessity of  ICS.
3. medication beliefs to be important determinants of  adherence to ICS, both in pa-
rents from primary care and in parents from secondary care (chapters 2, 3, and 5). 
4. major differences in the organization and content of  asthma care between 
primary and secondary care (chapters 2 and 5). Whilst children in primary care 
received education and instruction only once, and were seen for follow-up only 
when things were not going well, children and parents in secondary care received 
repeated and comprehensive self-management education, and were seen regularly 
for follow-up.
 
Taken together, these main results confirm our primary study hypothesis: parental 
medication beliefs are important determinants of  adherence to ICS in children with 
asthma in this study. In addition, this study showed major differences in quality of  
asthma care, medication beliefs and adherence between primary asthma care and 
secondary asthma care. 
The general discussion in this chapter focuses on the implications of  these obser-
vations: that good adherence can be achieved in most children with asthma, that 
modifying parental medication beliefs into adherence-promoting constructive beliefs 
is a key determinant of  such good adherence, and that patient-centred asthma care 
is required to modify these perceptions and improve adherence. This discussion is 
followed by a description of  the present lack of  patient-centred care, and of  the 
barriers to the implementation of  such care. We will also discuss the contribution of  
patient-centred communication to achieve good adherence. Towards the end of  this 
chapter, the thesis’s implications for practice and suggestions for future research will 
be presented. The main implication for clinical practice is that asthma, being a chronic 
disease, requires chronic attention and follow-up from the health care providers, with 
a focus on self-management education and discussing parental illness perceptions and 
medication beliefs, and modifying these beliefs when required. In adherence research, 
the focus up to now was always on the patients, driven by the question ‘why don’t 
patients take medications as prescribed by the physician?’. The results of  this thesis 
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strongly suggest, however, that future research should (also) be driven by the question 
‘How can a widespread adoption of  patient-centred communication in chronic health 
care be realized?’.
THE COMMON SENSE MODEL: MEDICATION BELIEFS DE-
TERMINE ADHERENCE
We found large differences in illness perceptions and medication beliefs between pa-
rents from the primary care group and those from the secondary care group, associa-
ted with different rates of  self-reported adherence to ICS (chapter 2). These qualita-
tive findings were supported quantitatively by the results of  the 1-yr follow-up study 
(chapters 3 and 5), which showed a high medication necessity perception in parents 
in secondary care, accompanied by very high median adherence, measured electroni-
cally. The limited variability in adherence to ICS hampered the study’s power to detect 
determinants of  adherence. Even at this high median level and limited degree of  
variation of  adherence, however, medication beliefs were the strongest predictors of  
adherence. Finally, the interviews with parents who completed the study also showed 
an association of  medication beliefs to adherence behaviour (chapter 7). The results 
of  these 3 studies therefore demonstrate a consistent pattern of  parental medication 
beliefs determining adherence to ICS in children (figure 1). This main outcome of  
the thesis, therefore, confirms our study hypothesis, and is in agreement with several 
studies which showed the pivotal role of  medication beliefs in determining adherence 
to ICS in adults and in children with asthma (table 1).1-5 
The results of  this study are in agreement with the self-regulation theory (or Com-
mon Sense Model) and the extended version of  this theory, which added medication 
beliefs to the model. This model highlights the pivotal role of  illness perceptions and 
medication beliefs as key determinants of  self-management and illness outcome, as 
was discussed in the general introduction. The model is not only strongly founded in 
medical psychological theory, but is also supported by numerous empirical observati-
ons in a range of  chronic conditions (reviewed in the introduction).6-8 As a result, the 
Common Sense Model provides a solid theoretical framework to discuss the highlights 
of  this thesis.
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Table 1. Quantitative studies on the relationship between parental medication beliefs and 
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Parents whose attitudes to medica-
tion was more concordant with the 
professional model of asthma had 
children who were more likely to be 
on an adequate medication regimen.
*: Beliefs about Medicines Questionnaire; ¶: higher scores reflect a more positive attitude 
toward preventive care, increased confidence to manage asthma attacks, and fewer concerns 
about side effects; ǂ:It keeps the asthma of my child under control, it reduces the risk of having 
an asthma attack; #: The Asthma Illness Representation Scale.
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INTERVENTIONS BASED ON THE COMMON SENSE MODEL
Following international asthma management guidelines, self-management education 
nowadays is a major component of  comprehensive asthma care.9 This is justified 
because self-management education has been shown to be effective in improving 
illness outcomes in a range of  chronic conditions, including childhood asthma.10-13 
Such education is primarily focused on improving patients’ and parents’ knowledge 
and self-management skills by providing unidirectional education (from the health care 
provider to patient and parents). The relationship of  such self-management education 
Figure 1. Patient adherence influenced by individual judgement and the role of asthma care as 
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in general
Beliefs about personal sensitivity
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and interpretation
Past experiences 






Patient adherence to medication is influenced by a number of factors relating to how the 
individual judges the necessity of their treatment relative to their concerns (as described by 
Horne57). Factors which can be modified by comprehensive asthma care, as suggested by the 
results of this thesis, moderating the reported association of asthma care and high adherence, 
are presented in black.
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and asthma outcomes may be moderated by improving knowledge and self-manage-
ment skills such as understanding the disease mechanism of  asthma and its triggers, 
proper inhalation technique, early recognition of  impending exacerbations, and the 
treatment of  such events. Because this kind of  education provides the basics needed 
for proper self-management, it can be concluded that it has incorporated the reality 
that patients (or their parents) have to manage their illness by themselves most of  
the time. However, increased knowledge and improved self-management skills per 
se are not associated with high adherence to inhaled corticosteroids, as illustrated by 
findings from a recent large review.5 Apparently, adherence to medication can only be 
improved to a limited degree by information-based and skills-based self-management 
education. 
This may be caused by the pivotal role of  illness perceptions and medication beliefs in 
determining self-management in general and adherence in particular. As discussed in 
chapter 1 of  this thesis, such individual perspectives are strongly influenced by cultu-
ral, social and psychological factors, and are hardly, if  at all, determined by ‘objective’ 
medical information. The results of  our study suggest that addressing and modifying 
illness perceptions and medication beliefs is of  key importance in determining the 
success of  self-management education in particular in achieving high adherence.
It is therefore important to examine the evidence on the effectiveness of  interventions 
in the context of  the central tenet of  the common sense model. If  illness perceptions 
determine outcome, then changing illness perceptions should lead to changes (i.e., im-
provements) in self-management and, therefore, in outcome. When medication beliefs 
determine adherence, changing counterproductive beliefs into constructive and useful 
medication beliefs may improve adherence. A number of  intervention studies support 
this hypothesis, in particular regarding the change of  illness perceptions.  For example, 
Jansen et al. described an intervention programme focused on changing both misper-
ceptions and negative perceptions of  illness and treatment. This programme increased 
the patients’ self-efficacy and stimulated social support, and showed encouraging 
results on short-term outcome in patients with end-stage renal disease.14 Comparable 
promising results of  interventions targeted on changing illness perceptions have been 
reported for patients with cardiac disease, diabetes and chronic low back pain.15-17 Very 
few studies, however, have examined interventions focused on modifying medication 
beliefs to improve adherence. To our knowledge, only Petrie et al. studied such an 
intervention by sending participants tailored text messages based on their illness and 
medication beliefs. In the intervention group, the perceived necessity of  preventer 
medication increased, and this was associated with higher self-reported adherence to 
ICS compared to the control group.18
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TAILORED SELF-MANAGEMENT EDUCATION MAY MODIFY 
ILLNESS PERCEPTIONS AND MEDICATION BELIEFS
Because of  the observational design of  this study and because illness perceptions and 
medication beliefs were assessed only once, this study provided no insight in indivi-
dual changes in these perceptions and beliefs from the moment of  referral to secon-
dary care throughout the comprehensive self-management education programme and 
follow-up. Although the study therefore does not directly demonstrate that illness 
perceptions and medication beliefs can be modified during comprehensive guideli-
ne-based asthma care in our secondary care setting, it does provide a considerable 
amount of  circumstantial evidence supporting this hypothesis. It also suggests that 
these changes in parental perspectives largely contributed to the high adherence rates 
we measured in the secondary care group. 
First, the focus group study (chapter 2) showed remarkable differences in medication 
beliefs between populations from primary and secondary care, and these differences 
in the perception of  the necessity of  ICS between parents from primary care and 
secondary care were confirmed at enrolment into the 12-month follow-up study 
(chapter 5). Because it can be assumed that parents in secondary care, at the time of  
referral to secondary care by their GP, had similar illness perceptions and medication 
beliefs as the parents from primary care examined in our study, it is likely that the ad-
herence-supporting constructive illness perceptions and medication beliefs developed 
during long-term management and follow-up in secondary care. 
Second, because of  the haphazard primary asthma care, without regular follow-up, a 
repetitive discussion of  parental perspectives was impossible. Secondary asthma care 
comprised extensive self-management education and regular follow-up, providing the 
opportunity to discuss parental perspectives repeatedly. Third, the perceived degree 
of  patient-centeredness was considerably higher in secondary than in primary care 
(chapter 5), suggesting a more collaborative physician-patient-parent partnership in 
secondary care, which is likely to increase the likelihood that parents and patients ac-
cept and internalize the adherence-promoting constructive medication beliefs that the 
health care providers present. This is supported by work by Petrie et al. who showed 
that patients’ medication beliefs can be modified by providing information tailored to 
the patient’s need after exploring their medication beliefs.18
Taken together, these observations support the hypothesis that exploring parental 
illness perceptions and medication beliefs, and providing tailored self-management 
education based on this, may help to modify medication necessity beliefs. This is the 
most likely explanation of  the strong association between guideline based comprehen-
sive asthma care and high adherence (figure 1). It suggests it is not the regular fol-
low-up itself, or the provision of  information-based and skills-based self-management 
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education, but that modification of  parental medication beliefs determines adherence. 
The discussion of  patients’ and parents’ perspectives, however, is missing in many 
consulting rooms, as will be discussed next.
THE REALITY OF THE CONSULTING ROOM 
We observed very limited self-management education and no regular follow-up for 
most patients in primary asthma care, both in the narratives provided by parents and 
by the GPs themselves (chapters 2 and 4). Previous studies in primary care settings in 
several countries, including the Netherlands, have shown comparable deviation from 
asthma guideline-based care.19-21 
Moreover, this finding is not unique for asthma, but has also been reported for a 
range of  other chronic illnesses. Recent surveys indicate that many physicians fail to 
provide self-management education on a regular basis, although there is now consis-
tent evidence supporting the effectiveness of  such education in patients with chronic 
illness.8,22-24 The lack of  attention to  adherence in follow-up consultations in daily 
practice is even more striking,25,26 to such an extent that it has been called a ‘conspira-
cy of  silence’. Our observations suggest that the conspiracy of  silence also includes 
insufficient attention to discussing illness perceptions and medication beliefs. This is 
in agreement with several studies showing a lack of  exploration of  the patient’s per-
spective in many medical consultations.26-31 The reality of  patients self-managing their 
illness, as determined by their illness perceptions and medication beliefs, is therefore 
not acknowledged in many consulting rooms. This is unfortunate as the results of  
this study strongly suggest that collaborating with parents of  children with a chronic 
disease such as asthma, taking their perspectives on the disease and its treatment into 
account, may help to improve adherence and to control asthma successfully. This 
approach has been termed “patient-centred care”, and consists of  three key elements 
(box 1).32,33 
Box 1. Domains of patient-centered care (adapted from 32, 33)
  -  discovering the patient’s perspective
  -  shared control of the consultation
  -  activating the patient to ask questions, prepare for consultations, and take initiative 
Accumulating evidence suggests that patient-centred care is associated with improved 
health outcomes.32,34 Most patients and parents prefer consultations which are organi-
zed along the principles of  patient-centred care. Although patient-centred care consul-
tations are therefore associated with increased patient satisfaction and improved health 
outcomes,32,35 many physicians experience obstacles to its adoption in daily practice.
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‘ACUTE CARE MODEL’ OR ‘COMMON SENSE MODEL’?
‘Although most practicing physicians will acknowledge that they are more involved 
in care than cure, the health care provided to patients with a chronic illness does not 
meet the patients’ needs, as outlined above. This may be related to organizational 
issues. The GPs in our study reported that the care provided in their practices was 
largely reactive in nature, aimed at delivering acute care to patients with current symp-
toms, but less tailored to chronic health care in children aimed at preventing future 
symptoms (chapters 2 and 4). Time constraints are also frequently mentioned as a 
reason to avoid discussing adherence.26,37 
Research has shown that patient-centred consultations indeed take slightly longer than 
traditional doctor-centred consultations.38 Because of  the limited time available to 
physicians in a single consultation, comprehensive self-management education is often 
outsourced to specialized nurses. In the primary care practices in our study, however, 
asthma nurses were not available for children with asthma (chapter 2); most specia-
lized nurses in primary care focus on disease management in chronic conditions of  
(elderly) adults, such as COPD and diabetes. The failure of  the financial health system 
to reimburse self-management education contributes to the persistence of  such orga-
nizational issues.39
A major barrier to providing patient-centred care and to discussing illness perceptions, 
medication beliefs, and adherence, is the absence  of  training of  such communication 
skills in current graduate and postgraduate medical education. Most medical students 
are now being sufficiently trained in basic communication skills, including eliciting the 
patient’s perspective and preferences.40  However, when these students enter clinical 
practice, they experience that many of  their role models show different professional 
communication behaviour altogether. Instead of  eliciting the patient’s perspective 
and agenda, most senior consultants perform their consultations in a doctor-centred 
fashion, and they do so with great confidence and efficiency.41 This lack of  training 
in and role-modelling of  patient-centred care may help to explain the ignorance and 
denial of  the patients’ perspective illustrated by the following quote that I took from a 
colleague paediatric registrar in my training department:
“Most medical students have images of  their future professional lives as young physicians, dressed 
in white coats that flutter while running through empty hallways late at night – heading for the 
emergency room where they will perform heroic, complex medical miracles, after which the patient 
will go home the next morning, completely recovered. To many of  them, it comes as quite a shock 
to learn about the ‘epidemiological transition’: the shift from ‘cure’ to ‘care’, and the shift from 
acute illness to chronic disease” 36
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“Parents come to the outpatient clinic with their child, because they want help with their 
child’s symptoms. I do my job well, by providing a diagnosis and prescribing medication. Why 
then don’t they follow my advice? They came to me because they wanted help! I give them good 
advice, what else do they want?”
Recognizable and understandable as this colleague’s heart cry may be, it does not 
reflect the reality that parents take decisions on the treatment of  their children based 
on their own illness perceptions and medication beliefs. Unfortunately, such ignorance 
is common among physicians. In a recent European study among GPs, large variati-
ons were noted between physicians, not only on their perspectives on asthma and its 
management, but also on how the doctor-patient relationship can be used optimally 
to treat the condition effectively.42 In the focus group interview with the GPs in our 
study, we recorded several beliefs about ICS which were not concordant with the 
current state of  the evidence, and these physician’s beliefs determined their prescrip-
tion behaviour (chapter 4). In another Dutch study, GPs reported the belief  that they 
could not modify patients’ attitudes to the use of  medication as an important reason 
to refrain from discussing adherence.26  
Such individual perspectives are major determinants of  behaviour, comparable to the 
main focus of  this thesis: the role of  patients’ perspectives about illness and medica-
tion in determining self-management behaviour as described by the Common Sense 
Model. Therefore, understanding physicians’ perspectives about the management of  
chronic diseases (particularly childhood asthma) may provide an explanation for the 
reason why these physicians prescribe long-term medication without providing the 
necessary self-management education and regular follow-up. Furthermore, such per-
spectives may hamper implementation of  patient-centred communication: providing 
patient-centred care requires a paradigm shift from the traditional medical care most 
physicians have been trained in.43 This change from physician-based asthma manage-
ment to patient-centred care is urgently needed, as discussed in the next section.
PATIENT-CENTRED COMMUNICATION: TIME TO CHANGE
The paucity of  randomized controlled trials studying the effect of  patient-centred 
interventions fuels an on-going discussion between believers and sceptics about the 
effectiveness of  patient-centred care. This paucity of  evidence from trials, however, is 
likely to remain for the following two reasons. First, patient-centred care is a complex 
multifaceted intervention. Clinical trials, mainly designed and suited to study straight-
forward drug interventions, are difficult to perform for such complex interventions, 
and their interpretation is fraught with difficulties.44 Second, documenting effects of  
patient-centred care on illness outcomes in chronic diseases requires long-term fol-
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low-up, which increases the complexity and cost of  trials, and reduces the willingness 
and possibilities of  researchers to embark on them. Criticasters of  patient-centred 
care can therefore rely on an on-going ‘absence of  evidence’ to support their rejection 
of  the concept. Because of  the substantial indirect evidence supporting the adopti-
on of  patient-centred care, this attitude appears to be short-sighted. Meanwhile, the 
disparity between the level of  evidence showing the effectiveness of  patient-centred 
care and the worldwide urgent call for patient-centred care is striking. The call for 
patient-centred care is driven by patient associations, which have developed a strong 
lobby on governmental institutes and quality-of-care institutes to encourage doctors to 
adopt patient-centred care.45,46 
This lobby reflects the almost universal patients’ preferences to collaborate with their 
doctors.47,48 The call for patient-centred care is also driven by an ethical and humanis-
tic  perspective as patient-centred care is increasingly being viewed as the paradigm of  
“good quality” care.49
Although these humanistic and ethical arguments may already provide sufficient rea-
son to implement patient-centred care, there also is accumulating evidence for a range 
of  chronic conditions showing the benefits of  patient-centred communication and 
care. A large systematic review reported a consistent relationship of  patient-centred 
communication to good adherence.50 We already discussed how tailored self-manage-
ment education, based on an assessment of  the patient’s and parents’ illness percepti-
ons and medication beliefs, and aimed at modifying these into adherence-promoting 
constructive beliefs, may improve adherence. Other patient-centred communication 
strategies may also be effective in improving adherence. These include shared decision 
making, motivational interviewing, and solution focused therapy.
• Shared decision making involves discussing patients’ perspectives during the medi-
cal consultation and negotiating towards a mutually agreed treatment plan, taking 
the patient’s context, goals, and perspectives into account. A recent proof-of-prin-
ciple study in adults with asthma showed improved adherence in adult patients 
with asthma involved in shared decision making, as compared to a control group 
receiving standard guideline-based therapy.51 Similar improvements in adherence 
and health outcomes have been noted for shared decision making in several other 
conditions in adults.52
• Motivational interviewing is a patient-focused method of  motivating behaviour 
change, centred on enhancing intrinsic motivation, and on resolving ambivalence 
about change. Through motivational interviewing, persons are guided to make 
self-care decisions based on their own personal goals and values. A number of  
studies reported benefits of  this communication strategy regarding self-manage-
ment behaviour and adherence.53-55 
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• Focusing on individual barriers which may hinder parents to achieve their in-
tended level of  adherence can also be a patient-centred communication strategy. 
Because of  the unique individual set of  barriers endangering optimal adherence 
in each case (as described in chapter 7), patient-centred interviewing is needed to 
detect such barriers. Because a parental lack of  motivation and ineffective pro-
blem-solving behaviour may underlie the persistence of  individual barriers, physi-
cians should address these problems (chapter 7). A study on physicians’ commu-
nication during follow-up consultations reported a lack of  focus on problems and 
suggested that physician collaborative communication can be most improved in 
the area of  participatory monitoring and problem solving.56  
IMPLICATIONS FOR PRACTICE
Childhood asthma care should be patient-centred, taking the reality of parents self-managing 
their child’s asthma into account, and the physician working as a coach. Such patient-centred 
care is characterized by:
• Information-based and skills-based self-management education
• Discussion of parental (and children’s) illness perceptions and medicationbeliefs
• Tailored self-management education
• Shared decision making
• Exploration of individual barriers to the use of ICS
• Regular follow-up
Child with asthma








Parents seek support by health care provider, but feel 
responsible for decisions in treatment
Coaching of parents: taking parental views 
and concerns seriously, giving advice about 
treatment and tailored education, educating 
self-management, supporting
Treatment at home as 
decided  by parents
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Taken together, patients’ preferences for collaborative care, the solid theoretical frame-
work of  the Common Sense Model supporting patient-centred care, the humanistic 
and ethical perspective that patient-centred care is the desirable paradigm for good 
quality health care, and the accumulating evidence showing the benefits of  such care 
justify the call for a paradigm shift in health care towards a widespread adoption of  
patient-centred care.
IMPLICATIONS FOR RESEARCH
In adherence research, the focus has traditionally been on the patients, driven by 
the question “why don’t patients take medications as prescribed by their physician?” 
Patient characteristics have been examined as potential determinants of  adherence. 
As confirmed in this study, the strongest patient determinants of  adherence are their 
illness perceptions and medication beliefs. In addition to this finding, this thesis also 
identified the organization of  health care and the approach of  the consultation as 
potentially important determinants of  adherence. Future adherence research should 
therefore not only target the patient, but also the health care provider, driven by the 
research question ‘How can widespread adoption of  patient-centred communication 
in chronic health care be realized?’. This latter research question can be addressed in 
different ways, including:
• A qualitative study on the views and preferences of  physicians on patient-cen-
tred care. What views do physicians have on the optimal organization of  health 
care and on their own consultations? How do they perceive the pros and cons of  
patient-centred versus doctor-centred consultations? What are the barriers they 
perceive to implementing patient-centred care? Do they feel sufficiently trained 
in applying the communication skills needed for patient-centred care? Does this 
differ between physicians in primary care versus those in hospital-based secondary 
and tertiary care?
• What approach do patients and parents prefer in health care for children? Do 
parents of  children universally prefer patient-centred care, or does this differ 
between parents? What are the determinants of  such differences, if  any, between 
parents? This can be approached quantitatively and qualitatively.
• How can communication skills for patient-centred care be taught? What is the 
optimal way of  teaching and practicing such communication skills? Is this applica-
ble for all aspects of  patient-centred care, including agenda setting, taking patient’s 
views and preferences into account, exploring illness perceptions and medicati-
on beliefs, shared decision making, and identifying barriers to adherence? What 
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implications do these findings have for the teaching of  communication skills in 
graduate and postgraduate medical education?
• What is the difference in time spent on consultations between traditional doc-
tor-centred and patient-centred consultations? What is the result of  such consul-
tations in paediatric practice in terms of  patient/parent satisfaction, in adherence 
and in health outcomes?
• What is the long-term cost-effectiveness of  patient-centred consultations as com-
pared to regular secondary care?
• In addition, this thesis gives rise to a number of  additional novel research areas 
which will only be described in broad and general terms. 
• Is motivational interviewing more effective than regular patient-centred care 
consultations for the adolescent with a chronic condition and known or suspected 
poor adherence to maintenance therapy?
• How do illness perceptions and medication beliefs change from the initial con-
sultation in secondary care at referral throughout long-term management and 
follow-up?
• Which communication strategy is most effective in modifying the patient’s and 
parents’ illness perceptions and medication beliefs? Does this differ between diffe-
rent groups of  patients?
CONCLUSIONS
Over the past decade, several systematic reviews reported limited effects of  interven-
tions to improve adherence, and a low overall adherence in medical care for paedia-
tric chronic diseases. This thesis, however, describes very high adherence in the large 
majority of  children with asthma in a secondary care practice providing guideline-ba-
sed comprehensive self-management education and follow-up in a patient-centred 
fashion. Based on the theoretical framework of  the Common Sense Model, we are 
convinced that the patient-centred tailored self-management education provided to 
the parents of  those children resulted in modification of  their medication beliefs, 
which in turn improved adherence. This justifies a paradigm shift in paediatric chro-
nic disease consultations from a traditional doctor- and disease-centred approach 
towards patient-centred care, taking the parents’ perceptions, beliefs, and preferences 
into account. This thesis also reported on the reality of  health care in daily practice, 
in which parental perspectives are not acknowledged or discussed in many consultati-
ons. Although organisational issues and lack of  specific training may play a role in this 
undesirable state of  affairs, physicians’ perspectives on the management of  chronic 
disease may be a more important determinant of  this lack of  attention to patients’ ill-
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ness perceptions and medication beliefs. Patient-centred communication incorporated 
in comprehensive asthma care with regular follow-up is a pivotal intervention to im-
prove adherence to medication, as shown by this study, and supported by several other 
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Kinderen met astma die daar regelmatig klachten van hebben, krijgen vaak het ad-
vies van een arts om dagelijks medicijnen te gebruiken. Die medicijnen zijn meestal 
corticosteroïden (net als bijvoorbeeld prednison) en worden ingenomen per inhaler. 
Deze inhalatiesteroïden hebben een ontstekingsremmend effect op het slijmvlies 
van de luchtwegen en verminderen de gevoeligheid van de luchtwegen voor prik-
kels waardoor de klachten van benauwdheid en piepen bij de ademhaling afnemen. 
Dagelijks gebruik van deze medicijnen, ook als er geen klachten zijn, heeft een goed 
beschermend effect; uit onderzoek blijkt dat vrijwel alle kinderen die deze medicijnen 
regelmatig gebruiken nauwelijks last hebben van hun astma. Ernstige bijwerkingen van 
deze medicijnen komen bijna nooit voor. In het kort is dit het medische model van 
astma en de behandeling daarvan. 
Uit onderzoek blijkt echter dat de meeste kinderen met astma hun medicijnen niet 
regelmatig gebruiken: er wordt vaak een dosering overgeslagen of  medicijnen worden 
alleen genomen als er klachten zijn. Het advies van de arts om de medicijnen regelma-
tig te nemen wordt dus niet gevolgd, dat wordt therapieontrouw genoemd. In interna-
tionale publicaties is de therapietrouw meestal tussen de 30% en 70%; een percentage 
dat weergeeft hoeveel van de voorgeschreven pufjes daadwerkelijk wordt genomen. 
Door therapieontrouw hebben veel kinderen onnodig veel last van hun astma.
Lange tijd bestond het beeld dat therapieontrouw vooral voorkwam bij bepaalde groe-
pen van ouders en kinderen. Bijvoorbeeld bij ouders die het advies van de arts niet 
goed begrepen (mogelijk in relatie met een lager opleidingsniveau) of  bij kinderen met 
milde astmaklachten. Dit is in onderzoek echter onjuist gebleken: therapieontrouw 
komt in alle lagen van de bevolking voor en is onafhankelijk van de ernst van de ziekte 
(zo wordt het zelfs ook gevonden bij kankerpatiënten of  na een orgaantransplantatie). 
In de afgelopen jaren is er daarom toenemend aandacht ontstaan voor andere deter-
minanten van therapieontrouw (factoren die samenhangen met therapieontrouw). Ge-
leidelijk aan is daarbij het beeld ontstaan dat het al of  niet gebruiken van medicijnen 
door kinderen met een chronische ziekte een meer of  minder bewuste keuze is van 
hun ouders. Ouders hebben hun eigen opvattingen over astma en over de behandeling 
er van, en deze opvattingen beïnvloeden hun keuze om het advies van de arts al of  




(boeren)verstand, en dit onderzoeksmodel van therapietrouw wordt dan ook het 
“Common Sense Model” genoemd. Ons onderzoek naar therapietrouw bij kinderen 
van twee tot twaalf  jaar met astma heeft als primaire hypothese dat ‘Common Sense’ 
een grotere invloed heeft op de therapietrouw dan factoren zoals de ernst van het 
astma of  de kennis van ouders over de ziekte. Deze achtergrond van het onderzoek is 
verder uitgewerkt in hoofdstuk 1.
In dit proefschrift staan verschillende studies beschreven die uitgevoerd zijn om deze 
hypothese te toetsen. De eerste studie is een focusgroep-onderzoek (groepsinter-
views) met ouders waarvan hun kind met astma onder behandeling is bij de huisarts 
of  de kinderarts (hoofdstuk 2). De tweede studie is een observationele studie, waarbij 
kinderen die van de huisarts of  van de kinderarts het advies kregen inhalatiesteroïden 
te gebruiken gedurende een jaar werden gevolgd. In dat jaar werd de therapietrouw 
gemeten met behulp van elektronische apparaatjes die op een microchip exact vast-
legden wanneer de medicatie gebruikt werd (zogenaamde medicatieloggers), en werd 
de astmacontrole bijgehouden. Opvattingen van ouders over astma en de medicatie 
werden vastgelegd met behulp van vragenlijsten. Daarnaast werd uitgebreid informatie 
verzameld over andere factoren die de therapietrouw zouden kunnen beïnvloeden, zo-
als de kennis van ouders over het astma, hun zorgen over de gezondheid van hun kind 
en de waardering van ouders voor de consulten van de arts. De uitkomsten van dit 
onderzoek zijn beschreven in hoofdstuk 3 tot en met 6. Na afloop van deze follow-up 
studie werden ouders uit het onderzoek geïnterviewd over het gebruik van de inhala-
tiesteroïden, zoals dat gedurende een jaar elektronisch was vastgelegd (hoofdstuk 7). 
Hieronder volgt een korte samenvatting van deze hoofdstukken, waarbij vanwege de 
overlap in methoden hoofdstuk 3 en 5 zijn samengevoegd. 
Het eerste artikel (hoofdstuk 2) beschrijft het focusgroep-onderzoek met ouders. Voor 
dit onderzoek werd 6 maal een groepsinterview gehouden: 3 met ouders waarvan hun 
kind door de huisarts werd behandeld en 3 met ouders waarvan hun kind door de kin-
derarts werd behandeld vanwege astma. De interviews waren gericht op het bespreken 
van de opvattingen van ouders over astma en het gebruik van inhalatiesteroïden. Er 
bleken grote verschillen te bestaan tussen ouders uit de huisartsengroep en de kin-
derartsengroep. In de eerste groep bleken ouders vaak opvattingen over astma en de 
medicatie te hebben die niet overeenkomen met het medische model van astma en 
de behandeling. Door deze opvattingen waren veel ouders niet bereid om hun kind 
dagelijks medicijnen toe te dienen, en werden de inhalatiesteroïden dus onregelmatig 
gebruikt. Ouders uit de kinderartsengroep hadden opvattingen die veel meer overeen-
kwamen met het medische model van astma, en dit was voor hen ook de rechtvaardi-
ging om hun kind regelmatig (dagelijks) de voorgeschreven medicatie toe te dienen. 
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Verder bleek de begeleiding van kinderen met astma door huisartsen vaak beperkt te 
zijn zonder regelmatige geplande controlebezoeken aan de huisarts. Dit in tegenstel-
ling tot de begeleiding die ouders ontvingen van de kinderarts en de kinderlongver-
pleegkundige in het ziekenhuis: uitgebreidere informatievoorziening waarbij het beleid 
werd afgestemd met ouders, gecombineerd met regelmatige geplande controlebezoe-
ken aan de polikliniek. 
Dit onderzoek laat zien dat veel ouders bewust een keuze maken of  ze het advies van 
de arts voor dagelijks gebruik van medicatie voor astma al dan niet opvolgen en dat 
zij zich bij die keuze laten leiden door hun eigen opvattingen over astma en medicatie. 
Verder toont dit onderzoek dat intensieve begeleiding van kinderen met astma en hun 
ouders samenhangt met opvattingen die overeenstemmen met het medische model 
van astma. Deze samenhang suggereert dat opvattingen van ouders over astma en de 
medicatie te veranderen zijn. Doordat het onderzoek gebaseerd was op de eigen rap-
portage van een relatief  klein aantal ouders, konden er geen algemene conclusies over 
alle ouders van alle kinderen met astma uit dit onderzoek worden getrokken.
Hoe de uitgebreide reeks van factoren die therapietrouw mogelijk beïnvloeden samen-
hangt met de therapietrouw zoals die gedurende een jaar elektronisch werd gemeten, 
is beschreven in hoofdstuk 3 en 5. De primaire hypothese van dit studieproject was 
dat opvattingen van ouders over astma en de medicatie de grootste invloed hebben 
op de therapietrouw, een hypothese die gevoed was door de resultaten uit het focus-
groep onderzoek uit hoofdstuk 2. Voor dit onderzoek zijn 42 kinderen met astma die 
door de huisarts werden behandeld en 135 kinderen met astma die door de kinderarts 
werden behandeld gedurende een jaar gevolgd. De inclusie van kinderen uit de huis-
artsenpraktijken verliep moeizaam omdat veel kinderen in de huisartspraktijk slechts 
korte tijd hun medicatie kregen voorgeschreven, waardoor deze groep relatief  klein is 
gebleven (dit is beschreven is in hoofdstuk 4). 
De eerste opvallende bevinding van dit onderzoek is de hoge mediane therapietrouw 
in de kinderartsengroep: 84% van de voorgeschreven pufjes werd genomen. In de 
huisartsengroep was dat duidelijk (en statistisch significant) lager: 66%. De mate waar-
in ouders de noodzaak zagen om dagelijks medicatie te gebruiken en de mate waarin 
zij zorgen hadden over het dagelijks gebruik van medicatie werd gescoord door middel 
van vragenlijsten. Bij ouders uit de kinderartsengroep was die score vaker in het voor-
deel van de noodzaak van medicatie dan bij ouders uit de huisartsengroep (91% versus 
75%), hun opvattingen kwamen dus vaker overeen met het medische model van astma 
en de behandeling. De kinderartsengroep kenmerkte zich door een beperkte spreiding 
in mate van therapietrouw en in de opvattingen over medicatie; veel ouders geloofden 
in de noodzaak van medicatie en gaven de medicatie ook regelmatig. 
De uitkomsten van dit onderzoek bevestigen de uitkomsten van het focusgroep 
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onderzoek: therapietrouw is bij de intensievere begeleiding in het ziekenhuis hoger, 
en dit hangt samen met opvattingen van ouders die beter overeenkomen met het 
medische model van de behandeling van astma, namelijk dat inhalatiesteroïden nodig 
zijn om een goede astmacontrole te bereiken. Overigens was de associatie tussen de 
opvattingen van ouders en therapietrouw binnen de kinderartsengroep slechts zwak 
vanwege de beperkte spreiding van therapietrouw (de meeste ouders gaven hun kind 
de medicatie dagelijks zoals voorgeschreven) en de beperkte spreiding in de opvatting 
dat inhalatiesteroïden nodig zijn (de meeste ouders erkenden de noodzaak er van). In 
combinatie met de uitkomsten van het focusgroep-onderzoek en omdat een sterke 
associatie tussen therapietrouw en opvattingen van ouders over de medicatie werd 
gevonden in de huisartsengroep, is het echter aannemelijk dat het verband tussen op-
vattingen over medicatiegebruik en therapie(on)trouw wel een oorzakelijke relatie is.
Het verschil in opvattingen over astma en het medicatiegebruik daarvoor tussen 
ouders uit de huisartsengroep en uit de kinderartsengroep veronderstelt dat zulke 
opvattingen te wijzigen zijn. Kinderen en ouders komen namelijk bij de kinderarts na 
verwijzing door de huisarts. Waarschijnlijk zijn hun opvattingen op het moment van 
verwijzing vergelijkbaar met ouders waarvan hun kind nog door de huisarts wordt be-
handeld. Door de intensieve begeleiding door de kinderarts en de kinderlongverpleeg-
kundige in de vorm van consulten die door ouders als duidelijk meer patiëntgericht 
worden beoordeeld dan de consulten bij de huisarts, is er in ieder geval volop gelegen-
heid om met ouders van gedachten te wisselen over hun opvattingen en om gerichte 
voorlichting te geven. Dat zulke gerichte voorlichting kan leiden tot veranderde op-
vattingen over astma en medicatie is door andere onderzoekers expliciet aangetoond. 
Daarmee zijn (gewijzigde) opvattingen van ouders over astma en de behandeling ervan 
dus niet alleen een belangrijke determinant van therapietrouw, maar ook de verbinding 
tussen de intensieve begeleiding op de polikliniek en de hoge therapietrouw die wij bij 
deze patiënten in dit onderzoek vonden.
Deze bevinding heeft belangrijke consequenties. Als er sprake is van therapieontrouw 
wordt nu vaak de ouder (of  de patiënt zelf) gezien als het ‘probleem’. De uitkomsten 
van dit onderzoek laten echter zien dat artsen een belangrijke rol kunnen hebben in 
het bereiken van goede therapietrouw, door ouders van kinderen met een chronische 
ziekte zoals astma voldoende begeleiding aan te bieden. Omdat veel ouders van kinde-
ren met astma deze noodzakelijke begeleiding niet ontvangen, is dit een veelbelovend 
aangrijpingspunt om de therapietrouw (en daardoor de astmacontrole, zie hoofdstuk 
6) bij kinderen met astma te verbeteren.
Omdat huisartsen vaak medicatie voorschrijven aan kinderen met terugkerende lucht-
wegklachten zonder dat ze daarbij expliciet de diagnose astma bij kinderen stellen, 
werden voor de inclusie van deze studie kinderen benaderd die in het afgelopen jaar 
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een recept voor inhalatiesteroïden ontvingen. Gebaseerd op de huisartsenrichtlijnen 
voor het voorschrijven van inhalatiesteroïden was de verwachting dat deze kinderen 
allemaal klachten zouden hebben (gehad) die bij astma passen. Tijdens telefonische 
interviews met de ouders van deze kinderen bleek dit echter niet het geval. Veel kinde-
ren aan wie inhalatiesteroïden waren voorgeschreven hadden klachten die niet ken-
merkend zijn voor astma, zoals hardnekkig hoesten of  benauwdheid bij inspanning. 
Meer dan de helft van alle kinderen die we benaderden (en dat waren dus alle kinderen 
aan wie inhalatiesteroïden in het afgelopen jaar was voorgeschreven) had in de drie 
maanden voor het telefonisch interview geen inhalatiesteroïden gebruikt, of  had deze 
medicijnen niet dagelijks gebruikt, maar alleen bij klachten. Volgens ouders was dat 
conform het voorschrift van de huisarts. De kinderen die volgens hun ouders wel 
dagelijks inhalatiesteroïden kregen werden gedurende een jaar gevolgd. Ook van deze 
kinderen bleek een gedeelte geen astmaklachten te hebben of  de medicatie onregelma-
tig te gebruiken op advies van de huisarts. In een groepsinterview bevestigden de huis-
artsen dat zij inhalatiesteroïden laagdrempelig voorschreven aan kinderen met lucht-
wegklachten anders dan astma en dat zij vaak het advies geven om de medicatie alleen 
bij klachten te gebruiken. Een aantal redenen lag ten grondslag aan dit voorschrijfge-
drag dat dus afwijkt van de huisartsenrichtlijn voor astmabehandeling. Soms schreven 
de huisartsen inhalatiesteroïden voor om een periode met klachten zonder duidelijke 
oorzaak te overbruggen, soms was het bedoeld als een start van astmabehandeling. 
Voor de huisartsen wogen de voordelen van deze praktijk op tegen de nadelen. Toch 
kregen veel kinderen door dit voorschrijfgedrag inhalatiesteroïden toegediend, soms 
gedurende langere tijd, terwijl dit volgens de richtlijnen voor astmabehandeling niet 
nodig en ook niet zinvol was. Aan de andere kant werden de kinderen met astma in de 
huisartspraktijk vaak niet optimaal behandeld: zij kregen niet het advies om de medi-
catie dagelijks te gebruiken. Dit onderzoek laat zien dat het onregelmatige gebruik van 
inhalatiesteroïden bij kinderen zoals dat in veel onderzoek wordt gevonden niet alleen 
het gevolg is van ouders die adviezen niet opvolgen, maar ook van het voorschrijfge-
drag van huisartsen. 
Het is waarschijnlijk dat hogere therapietrouw leidt tot betere astmacontrole. In 
hoofdstuk 6 wordt deze hypothese getoetst bij de kinderen van twee tot zes jaar oud 
die behandeld worden door de kinderarts. Gedurende het jaar dat de therapietrouw 
werd gemeten werd de mate van astmacontrole bij deze kinderen met verschillende 
methoden vastgelegd. Ouders vulden om de drie maanden vragenlijsten in en kin-
derartsen en kinderlongverpleegkundigen scoorden hun inschatting van de mate van 
astmacontrole tijdens de controlebezoeken van de deelnemende kinderen aan de 
polikliniek. Daarnaast werd longfunctieonderzoek verricht. Ondanks de hoge mediane 
therapietrouw en de beperkte spreiding van de therapietrouw in deze groep kinderen 
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werd een sterk lineair verband gevonden tussen de therapietrouw en de mate van 
astmacontrole. Kinderen die meer dan 80% van de voorgeschreven medicatie kregen, 
hadden de minste klachten en aanvallen van hun astma. Kinderen met lagere therapie-
trouw hadden vooral aanhoudend milde klachten van hun astma. Voor artsen die kin-
deren met astma behandelen is het dus belangrijk om bij kinderen met aanhoudende 
milde klachten aandacht te besteden aan de therapietrouw om ook bij deze kinderen 
zo goed mogelijke astmacontrole te bereiken.
Ondanks de hoge mediane therapietrouw bij kinderen behandeld door de kinderarts, 
kregen ook in deze groep sommige kinderen duidelijk minder medicatie dan was 
voorgeschreven. Om meer duidelijkheid te krijgen over de achtergronden van de lage 
therapietrouw in sommige gezinnen, ondanks intensieve begeleiding, werden ouders 
geïnterviewd over de mate van therapietrouw zoals die gedurende een jaar was vast-
gelegd (hoofdstuk 7). Na interviews met 10 ouders (en kinderen) met een lage thera-
pietrouw werden 10 ouders (en kinderen) met een hoge therapietrouw geïnterviewd. 
Deze laatste interviews maakten het mogelijk om te bestuderen waarom factoren in 
het ene gezin wel en in het andere gezin niet tot therapieontrouw leiden. 
Drie patronen van therapieontrouw werden geïdentificeerd. Ten eerste, ouders die 
zeer bewust het advies van de arts niet opvolgden op basis van hun opvattingen over 
astma en de behandeling. Ten tweede, gezinnen waar regelmatig een dosis werd gemist 
zonder vooropgezet plan. Dit kwam vooral voor bij ouders die ook andere zorgen aan 
hun hoofd hadden, zoals problemen met de opvoeding van de kinderen of  financiële 
zorgen. Het derde patroon van therapieontrouw werd gekenmerkt door kinderen die 
al op jonge leeftijd (vanaf  8 jaar) de volledige verantwoordelijkheid kregen voor het 
dagelijks nemen van hun medicijnen, zonder toezicht van of  controle door de ouders. 
Deze kinderen namen de medicatie vaak veel minder vaak dan de ouders verwachtten. 
Dit laatste patroon is een oorzaak van therapieontrouw die nauwelijks bekend is en 
waar nog weinig onderzoek naar is verricht. Het geeft wel een goed aanknopingspunt 
voor verbetering van de therapietrouw. Artsen en verpleegkundigen kunnen de verant-
woordelijkheid die kinderen aan kunnen bespreken met ouders: kinderen op de basis-
schoolleeftijd zijn dus nog niet in staat om volledige verantwoordelijkheid te dragen 
voor het dagelijks gebruik van onderhoudsmedicatie voor een chronische ziekte.
In hoofdstuk 8 worden alle resultaten van het onderzoek bediscussieerd in het licht 
van actuele wetenschappelijke publicaties over therapietrouw en de zorg voor pati-
enten met een chronische ziekte. In overeenstemming met deze publicaties laat ons 
onderzoek zien dat opvattingen over ziekte en medicatie de therapietrouw in sterke 
mate bepalen. De primaire hypothese van het onderzoek, namelijk dat zulke opvat-
tingen een grotere invloed hebben op de therapietrouw dan factoren zoals de ernst 
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van het astma of  de kennis van ouders over de ziekte, wordt daarmee bevestigd. De 
uitkomsten van dit onderzoek wijzen erop dat zulke opvattingen kunnen veranderen, 
wanneer er in voldoende mate en op de juiste manier met ouders wordt gecommuni-
ceerd. Er zijn slechts enkele andere onderzoeken die deze bevinding direct steunen. 
Wel is er een groot aantal onderzoeken dat laat zien dat patiënten vaker het advies 
opvolgen van artsen die patiëntgericht communiceren. Een voorbeeld van zulke pati-
entgerichte communicatie is Shared Decision Making (gezamenlijke besluitvorming). 
Hierbij staat het actief  inventariseren van de opvattingen van de patiënt over de ziekte 
en diens wensen over de behandeling centraal, waarbij die opvattingen en wensen 
worden meegenomen in een gezamenlijk genomen besluit over de behandeling. Voor 
deze vorm van arts-patiëntcommunicatie is aangetoond dat het de therapietrouw po-
sitief  beïnvloedt. Ondersteund door deze bevindingen is het aannemelijk dat de hoge 
therapietrouw zoals die gemeten is in de populatie kinderen die behandeld wordt door 
de kinderarts samenhangt met de wijze waarop kinderen worden begeleid en de wijze 
waarop met ouders wordt gecommuniceerd. 
Een andere belangrijke constatering van dit onderzoek is dat de astmazorg zoals die 
door huisartsen wordt gegeven tekortkomingen vertoont. De beperkte begeleiding 
van kinderen met astma en hun ouders in de huisartsenpraktijk beperkt de mogelijk-
heden tot een goede afstemming van het behandelbeleid met ouders. Opvattingen 
van ouders en patiënten komen in de spreekkamer meestal niet aan bod, vaak door 
(vermeend) tijdgebrek. Er zijn echter ook aanwijzingen dat artsen zich onvoldoende 
realiseren in welke mate patiënten een bewuste keuze maken om een medicatieadvies 
te volgen en daarin geleid worden door hun eigen opvattingen. In de opleiding van 
artsen wordt relatief  weinig aandacht besteed aan de communicatie met patiënten met 
een chronische aandoening. Dat kan een goede verklaring vormen voor de beperkte 
aandacht in veel spreekkamers voor het perspectief  van de patiënt.
Vele onderzoeken tonen een lage therapietrouw voor inhalatiesteroïden bij kinderen 
met astma. Hierdoor houden veel kinderen onnodig klachten. Uit dit onderzoek, en 
in overeenstemming met internationale publicaties, blijkt dat de zorg voor kinderen 
met astma vaak niet aan de richtlijnen voldoet en dat de communicatie met ouders 
onvoldoende patiëntgericht is. In dit onderzoek vinden wij een ongeëvenaard hoge 
therapietrouw bij een groep kinderen met astma die intensieve en patiëntgerichte be-
geleiding ontving op een polikliniek waar kinderartsen en kinderlongverpleegkundigen 
samen de zorg voor kinderen met astma en hun ouders gestalte geven. Dit onderzoek 
laat dus zien dat goede therapietrouw haalbaar is voor de meeste kinderen met astma, 
samen met een goede controle van hun astma. Dit is voor veel meer kinderen met 
astma haalbaar als zij en hun ouders de juiste intensieve zorg en begeleiding ontvan-
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gen. Lange tijd werd vooral naar die ouders gekeken als het ging om therapieontrouw: 
zij volgden niet het voorschrift van de arts. Dit onderzoek maakt duidelijk dat er ook 
aandacht moet zijn voor de begeleiding die artsen geven aan ouders van kinderen met 
astma. Krijgen deze ouders de begeleiding die zij nodig hebben om een goede keuze te 
maken in de behandeling van hun kind met astma? De medische wereld kan zelf  veel 
doen om de zorg voor kinderen met een chronische ziekte zoals astma te verbeteren. 
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Wat een inspiratie heeft dit promotieproject mij gebracht! Het heeft mijn kijk op de 
arts-patiënt relatie sterk veranderd, en daarmee ook de wijze waarop ik mijn dagelijks 
werk doe. Het heeft mij enthousiast gemaakt om zorg aan patiënten met een chroni-
sche ziekte te verbeteren. Ik ben ervan overtuigd geraakt dat hierin nog een wereld te 
winnen is.
 “Niet alleen de inhoud van mijn onderzoek was buitengewoon inspirerend, dat geldt 
zeker ook voor het contact met mijn begeleiders”. De eerste van hen die ik bedank is 
professor Ad Kaptein. Hij heeft me voortdurend gestimuleerd om te luisteren naar de 
patiënt en de ouders, hun verhaal te horen. Zijn bevlogenheid en zijn enorme inzet 
waren een goede motivatie om door te zetten, ook als het minder soepel liep. ‘Doc, 
doorgaan….’, luidde dan weer de titel van een mailtje. De topografische afstand tussen 
ons was groot en we hebben elkaar weinig ontmoet. Maar de begeleiding via de mail 
was van uitstekend niveau. Van grap en grol tijdens lange, saaie bureaudagen tot inspi-
rerende tips en de soms broodnodige steun. Ik denk zelfs dat de topografische afstand 
onze relatie goed heeft gedaan; door jouw vorm van communicatie vergat ik meestal 
dat je een (bijna) emeritus-professor uit het keurige Leiden bent. Dat gaf  vrijheid in 
onze correspondentie. Ad, bedankt.
Juist heel dichtbij was professor Paul Brand. Beste Paul, enkele jaren spraken wij elkaar 
vrijwel elke maandag tijdens de lunch. Afgewisseld met een bezoek bij jou thuis aan de 
keukentafel of  in de tuin. De uitkomsten van het onderzoek waren ook voor jou een 
eyeopener. Jouw geestdrift voor dit onderzoek, voor de verrassende uitkomsten ervan 
en voor de implicaties rond de zorg aan kinderen met astma was een enorme stimu-
lans. Door je directe betrokkenheid was je goed op de hoogte van de lastige fasen in 
het onderzoek; je altijd positieve insteek was opbeurend. Door de vertragingen die het 
onderzoek opliep, moest het opschrijven van de resultaten in korte tijd plaatsvinden. 
Dankzij jouw hulp is het gelukt om in vijf  maanden tijd vier manuscripten, de ‘intro-
duction’ en ‘general discussion’ te schrijven. Gecorrigeerd in het vliegtuig onderweg 
naar vakantie of  tijdens een congres in het buitenland: ik kreeg mijn stukken altijd in 




en effectiviteit waren een enorme stimulans om steeds weer een tandje bij te zetten, 
waardoor sommigen mij inmiddels een workaholic noemen. Bedankt voor alles. 
Professor Eric Duiverman was de derde begeleider bij dit onderzoeksproject. Beste 
Eric, door de rol die je had binnen het onderzoek was ons contact veel minder fre-
quent. Jij was de begeleider die vaak vanuit de coulissen meedeed. Je dacht mee met de 
ontwikkelingen binnen het onderzoek en probeerde met je nuchtere commentaar op 
de manuscripten ons enthousiasme in toom te houden. Bedankt voor je adviezen en 
inzet.
Naast Paul waren vooral Eric de Groot als kinderarts en Lia van Helsdingen en 
Jacqueline Wolf  als kinderlongverpleegkundigen degenen die de astmazorg op de 
polikliniek kindergeneeskunde van de Isala klinieken realiseerden ten tijde van het on-
derzoek. Het grootste deel van de onderzochte patiëntenpopulatie was bij hen onder 
controle. Bedankt voor jullie bijdrage aan het includeren van patiënten en het invullen 
van vragenlijsten. 
Dat het onderzoek ook uitgevoerd kon worden in de eerste lijn heeft een essentiële 
meerwaarde gehad voor de uitkomsten. Mijn dank aan de huisartsen die hun mede-
werking gaven is dan ook groot. Het was zeker niet vanzelfsprekend dat jullie ons 
vanuit de tweede lijn een kijkje gaven in jullie praktijk van kinderastmazorg. Ook toen 
na de interviews met ouders duidelijk werd dat die zorg misschien wel beter kon, 
wilden jullie zonder aarzeling meewerken aan een vervolg. Tweemaal hadden we een 
bespreking over de uitkomsten van dit onderzoek. Uitkomsten die lieten zien hoe 
anders de benadering is binnen de eerste lijn versus de tweede lijn. Ondanks die grote 
verschillen lukte het ons om daar op een open en eerlijke manier over te discussiëren. 
Wat mij betreft is dit een groot compliment aan jullie en een voorbeeld hoe we kunnen 
samenwerken om tot betere (keten)zorg te komen.
In het ziekenhuis waren natuurlijk veel meer mensen direct en indirect betrokken bij 
de zorg voor kinderen met astma en daarmee bij het onderzoek. De kinderartsen, het 
secretariaat, de longfunctieassistenten: doordat iedereen altijd weer een bijdrage wilde 
leveren, verliep het onderzoek voorspoedig en met weinig frustratie. De sfeer op de 
Amalia kinderafdeling is goed, dat maakt dat ik daar jaren met veel plezier heb ge-
werkt. Zowel in de periode dat ik volledig bezig was met onderzoek als de periode dat 
ik de stages liep voor mijn opleiding tot kinderarts. 
Met Hanna beet ik de spits van het onderzoek af: we werkten samen intensief  aan het 
focusgroep onderzoek. Interviews uitwerken is een tijdrovende klus waar jouw hulp 
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meer dan welkom was. Ook Susanne werkte mee aan een interviewstudie, maar dan 
juist aan het einde van het onderzoek. Je hebt daar heel wat uren in gestoken. Bijzon-
der aan dat onderzoek waren de gezamenlijke bezoeken bij ouders thuis, meestal in de 
avonduren. Wouter, ook jij bedankt voor je bijdrage, niet in het minst voor onze ont-
spannende tafelvoetbalcompetitie die ik kansloos verloor. Om de uitval van patiënten 
laag te houden, werden ouders en kinderen soms thuis bezocht. Daarnaast moesten 
altijd weer de medicatieloggers worden uitgelezen en vragenlijsten afgenomen, ook als 
ik bezig was met mijn (poli)klinische werkzaamheden. Dat was een tijdrovende klus 
waar Wouter, Susanne, Cirsten en Wilma mij fantastisch bij hielpen. Zonder jullie hulp 
was het nooit gelukt om het onderzoek door te laten lopen tijdens de fase dat ik mijn 
opleiding tot kinderarts hervatte.
En natuurlijk wil ik alle ouders en kinderen bedanken. Door jullie bereidheid mee 
te werken aan het onderzoek is dit succes behaald. Vele vragenlijsten invullen, extra 
longfunctie blazen, extra afspraken in het ziekenhuis of  thuis: het gebeurde allemaal 
zonder veel problemen. Over de vanzelfsprekendheid om mee te werken aan dit on-
derzoek ben ik nog altijd blij verrast. 
En dan is het onderzoek af, de manuscripten geschreven en naar de leescommis-
sie verstuurd. Dan gaan plotseling alle verplichtingen rond promoveren de agenda 
beheersen. Rick, Simen en Rieke, bedankt voor jullie bijdragen aan teksten lezen en 
redigeren, het opmaken van mijn proefschrift en het ontwikkelen van de door mij zo 
begeerde website. En Els en Nynke, wat ontzettend leuk dat jullie mijn paranimfen 
willen zijn. Ik voel me vereerd. 
Voor mijn gezin(sleven) was het onderzoek eerder een zegen dan een vloek, of  beter 
eerst een zegen en later een vloek. Door de vrije dag in de week en de flexibiliteit kon 
ik in de drukke jaren met twee kleine kinderen de zorg goed met je delen, Rieke. Tij-
dens de laatste loodjes was dat anders, zeker de laatste maanden met de voortzetting 
van mijn opleiding in het UMCG. Lange werkweken met weinig aandacht voor jou en 
voor Simon en Hilde. Terwijl jullie zo belangrijk zijn voor mijn plezier in het leven en 
mij met beide voeten op de grond houden. Zoals Simon mij als 4-jarige al zei tijdens 
een meningsverschil: “Papa, jij weet ook niet alles”. En zo is het maar net! 
